PCT (PCTL) 10-Q/A 23 Dec 21 2021 Q3 Quarterly report (amended) Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2021	Nov. 15, 2021
Cover [Abstract]
Document Type	10-Q/A
Amendment Flag	true
Amendment Description	EXPLANATORY NOTE
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2021
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--12-31
Entity File Number	000-31549
Entity Registrant Name	PCT LTD
Entity Central Index Key	0001119897
Entity Tax Identification Number	90-0578516
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	4235 Commerce Street
Entity Address, City or Town	Little River
Entity Address, State or Province	SC
Entity Address, Postal Zip Code	29566
City Area Code	843
Local Phone Number	390-7900
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		788,376,229

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
CURRENT ASSETS
Cash and cash equivalents	$ 239,327	$ 115,196
Accounts receivable, net	163,147	349,526
Inventory	12,318	6,188
Prepaid expenses	168,136	274,736
Other current assets	18,850	2,110
Total current assets	601,778	747,756
PROPERTY AND EQUIPMENT
Property and equipment, net	320,131	358,719
OTHER ASSETS
Intangible assets, net	3,171,658	3,400,024
Operating lease right-of-use asset	92,772	118,385
Deposits		9,726
Total other assets	3,264,430	3,528,135
TOTAL ASSETS	4,186,339	4,634,610
CURRENT LIABILITIES
Accounts payable	60,854	272,978
Accrued expenses - related parties	82,038	139,280
Accrued expenses	707,450	622,040
Deferred revenue	1,075	1,075
Advances payable	1,450,000
Current portion of operating lease liability	40,127	34,965
Current portion of notes payable - related parties, net	154,271	789,214
Current portion of notes payable, net	231,504	384,380
Current portion of convertible notes payable, net	1,876,338	1,554,503
Derivative liability	1,561,420	7,102,801
Total current liabilities	6,165,077	10,901,236
LONG-TERM LIABILITIES
Convertible notes payable, net of current portion and discounts		53,500
Operating lease liability, net of current portion	52,645	83,420
TOTAL LIABILITIES	6,217,722	11,038,156
MEZZANINE EQUITY
Preferred series A stock, $0.001 par value; 1,000,000 authorized; 500,000 and 500,000 issued and outstanding at September 30, 2021 and December 31, 2020, respectively	60,398	60,398
Preferred series B stock, $0.001 par value; 1,000,000 authorized; 1,000,000 and 1,000,000 issued and outstanding at September 30, 2021 and December 31, 2020, respectively	158,247	158,247
Preferred series C stock, $0.001 par value; 5,500,000 authorized; nil and 40,000 issued and outstanding at September 30, 2021 and December 31, 2020, respectively		40,000
TOTAL MEZZANINE EQUITY	218,645	258,645
STOCKHOLDERS' DEFICIT
CCommon stock, $0.001 par value; 1,000,000,000 authorized; 780,126,229 and 722,487,846 issued and outstanding at September 30, 2021 and December 31, 2020, respectively	780,126	722,488
Additional paid-in-capital	24,349,886	23,202,933
Accumulated deficit	(27,380,040)	(30,587,612)
TOTAL STOCKHOLDERS' DEFICIT	(2,250,028)	(6,662,191)
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT	$ 4,186,339	$ 4,634,610

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	1,000,000,000	1,000,000,000
Common Stock, Shares, Issued	780,126,229	722,487,846
Common Stock, Shares, Outstanding	780,126,229	722,487,846
Series A Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	1,000,000	1,000,000
Preferred Stock, Shares Issued	500,000	500,000
Preferred Stock, Shares Outstanding	500,000	500,000
Series B Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	1,000,000	1,000,000
Preferred Stock, Shares Issued	1,000,000	1,000,000
Preferred Stock, Shares Outstanding	1,000,000	1,000,000
Series C Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	5,500,000	5,500,000
Preferred Stock, Shares Issued		40,000
Preferred Stock, Shares Outstanding		40,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
REVENUES
Product	$ 33,279	$ 488,021	$ 204,138	$ 1,233,058
Licensing	75,347	119,000	225,122	203,000
Equipment leases	258,104	177,067	802,132	501,384
Total Revenues	366,730	784,088	1,231,392	1,937,442
OPERATING EXPENSES
General and administrative	1,031,072	614,667	2,583,139	1,755,495
Research and development	14,783	15,547	29,738	20,547
Cost of product, licensing and equipment leases	85,591	54,901	225,960	619,606
Depreciation and amortization	98,364	90,999	295,092	255,368
Total operating expenses	1,229,810	776,114	3,133,929	2,651,016
Income (loss) from operations	(863,080)	7,974	(1,902,537)	(713,574)
OTHER INCOME (EXPENSE)
Gain (loss) on change in fair value of derivative liability	457,116	57,054	1,749,277	(15,253,543)
Gain (loss) on settlement of debt	361,357	(3,670,393)	3,689,055	9,993,528
Interest expense	(101,580)	(200,593)	(378,223)	(1,094,934)
Miscellaneous income			50,000
Total other income (expense)	716,893	(3,813,932)	5,110,109	(6,354,949)
Income (loss) before Income taxes	(146,187)	(3,805,958)	3,207,572	(7,068,523)
Income taxes
NET INCOME (LOSS)	(146,187)	(3,805,958)	3,207,572	(7,068,523)
Preferred series C stock deemed dividends				(270,000)
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS'	$ (146,187)	$ (3,805,958)	$ 3,207,572	$ (7,338,523)
Basic income (loss) per share	$ 0	$ (0.01)	$ 0	$ (0.01)
Diluted income (loss) per share	$ 0	$ (0.01)	$ 0	$ (0.01)
Basic weighted average shares outstanding	773,082,751	608,601,357	760,229,694	575,094,639
Diluted weighted average shares outstanding	773,082,751	608,601,357	1,024,432,537	575,094,639

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance - December 31, 2020 at Dec. 31, 2019	$ 498,881	$ 15,872,330	$ (26,505,567)	$ (10,134,356)
Beginning balance, shares at Dec. 31, 2019	498,880,300
Common stock issued for services	$ 15,525	103,538		119,063
Common stock issued for services, shares	15,525,000
Common stock issued in settlement of debt	$ 250	7,975		8,225
Common stock issued in settlement of debt, shares	250,000
Common stock issued in conversion of convertible notes payable	$ 36,050	360,660		396,710
Common stock issued in conversion of convertible notes payable, shares	36,050,000
Beneficial conversion feature on preferred series C stock		270,000	(270,000)
Net loss			(10,281,648)	(10,281,648)
Balance - September 30, 2021 at Mar. 31, 2020	$ 550,706	16,614,503	(37,057,215)	(19,892,006)
Ending balance, shares at Mar. 31, 2020	550,705,300
Balance - December 31, 2020 at Dec. 31, 2019	$ 498,881	15,872,330	(26,505,567)	(10,134,356)
Beginning balance, shares at Dec. 31, 2019	498,880,300
Net loss				(7,068,523)
Balance - September 30, 2021 at Sep. 30, 2020	$ 674,938	23,457,582	(33,844,090)	(9,711,570)
Ending balance, shares at Sep. 30, 2020	674,937,846
Common stock issued in cashless exercise of warrants				429,948
Balance - December 31, 2020 at Mar. 31, 2020	$ 550,706	16,614,503	(37,057,215)	(19,892,006)
Beginning balance, shares at Mar. 31, 2020	550,705,300
Common stock issued in settlement of debt	$ 15,000	826,500		841,500
Common stock issued in settlement of debt, shares	15,000,000
Net loss			7,019,083	7,019,083
Balance - September 30, 2021 at Jun. 30, 2020	$ 584,202	18,056,637	(30,038,132)	(11,397,293)
Ending balance, shares at Jun. 30, 2020	584,201,486
Common stock issued for cash	$ 4,250	135,750		140,000
Common stock issued for cash, shares	4,250,000
Common stock issued in cashless exercise of warrants	$ 9,246	420,702		429,948
Common stock issued in cashless exercise of warrants, shares	9,246,186
Common stock issued in conversion of preferred series C stock	$ 5,000	45,000		50,000
Common stock issued in conversion of preferred series C stock, shares	5,000,000
Stock-based compensation		14,182		14,182
Common stock issued for services	$ 10,000	384,038		394,038
Common stock issued for services, shares	10,000,000
Common stock issued in conversion of convertible notes payable	$ 45,736	497,222		542,958
Common stock issued in conversion of convertible notes payable, shares	45,736,360
Net loss			(3,805,958)	(3,805,958)
Balance - September 30, 2021 at Sep. 30, 2020	$ 674,938	23,457,582	(33,844,090)	(9,711,570)
Ending balance, shares at Sep. 30, 2020	674,937,846
Common stock issued in conversion of preferred series C stock	$ 35,000	359,000		394,000
Common stock issued in conversion of preferred series C stock, shares	35,000,000
Premium related to conversion feature on note payable		4,160,685		4,160,685
Balance - December 31, 2020 at Dec. 31, 2020	$ 722,488	23,202,933	(30,587,612)	(6,662,191)
Beginning balance, shares at Dec. 31, 2020	722,487,846
Common stock issued for services	$ 2,500	74,276		76,776
Common stock issued for services, shares	2,500,000
Common stock issued in settlement of debt	$ 4,466	648,844		653,310
Common stock issued in settlement of debt, shares	4,466,508
Common stock issued in conversion of convertible notes payable	$ 25,000			$ 25,000
Common stock issued in conversion of convertible notes payable, shares	25,000,000			25,000,000
Net loss			(718,028)	$ (718,028)
Balance - September 30, 2021 at Mar. 31, 2021	$ 758,454	23,962,053	(31,305,640)	(6,585,133)
Ending balance, shares at Mar. 31, 2021	758,454,354
Common stock issued in conversion of preferred series C stock	$ 4,000	36,000		$ 40,000
Common stock issued in conversion of preferred series C stock, shares	4,000,000			4,000,000
Balance - December 31, 2020 at Dec. 31, 2020	$ 722,488	23,202,933	(30,587,612)	$ (6,662,191)
Beginning balance, shares at Dec. 31, 2020	722,487,846
Net loss				3,207,572
Balance - September 30, 2021 at Sep. 30, 2021	$ 780,126	24,349,886	(27,380,040)	(2,250,028)
Ending balance, shares at Sep. 30, 2021	780,126,229
Common stock issued in cashless exercise of warrants				34,594
Balance - December 31, 2020 at Mar. 31, 2021	$ 758,454	23,962,053	(31,305,640)	(6,585,133)
Beginning balance, shares at Mar. 31, 2021	758,454,354
Common stock issued for services	$ 1,000	32,174		33,174
Common stock issued for services, shares	1,000,000
Net loss			4,071,787	4,071,787
Balance - September 30, 2021 at Jun. 30, 2021	$ 770,126	24,193,149	(27,233,853)	(2,270,578)
Ending balance, shares at Jun. 30, 2021	770,126,229
Common stock issued for cash	$ 8,750	166,250		175,000
Common stock issued for cash, shares	8,750,000
Common stock issued in cashless exercise of warrants	$ 1,922	32,672		34,594
Common stock issued in cashless exercise of warrants, shares	1,921,875
Common stock issued for services	$ 2,000	40,737		42,737
Common stock issued for services, shares	2,000,000
Common stock issued in conversion of convertible notes payable	$ 8,000	116,000		124,000
Common stock issued in conversion of convertible notes payable, shares	8,000,000
Net loss			(146,187)	(146,187)
Balance - September 30, 2021 at Sep. 30, 2021	$ 780,126	$ 24,349,886	$ (27,380,040)	$ (2,250,028)
Ending balance, shares at Sep. 30, 2021	780,126,229
Common stock issued in cashless exercise of warrants, shares				1,921,875

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash Flows from Operating Activities
Net loss	$ 3,207,572	$ (7,068,523)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	295,092	255,368
Amortization of debt discounts	240,413	353,012
Amortization of operating lease right-of-use asset	39,182
Common stock issued for services	267,830	527,283
Loss on change in fair value of derivative liability	(1,749,277)	15,253,543
(Gain) loss on settlement of debt	(3,689,055)	(9,993,528)
Default penalties on convertible notes payable	15,172	13,762
Bad debt expense	182,700
Changes in operating assets and liabilities:
Accounts receivable	3,679	(157,076)
Inventory	(6,130)	26,669
Prepaid expenses	(8,543)	(241,764)
Other assets	(16,740)	(3,853)
Deposits	9,726
Operating lease liability	(39,182)
Accounts payable	(212,125)	(87,369)
Accrued expenses - related party	14,887	27,071
Accrued expenses	165,479	807,049
Net cash used in operating activities	(1,279,320)	(288,356)
Cash Flows from Investing Activities
Purchases of property and equipment	(28,138)	(127,212)
Net cash provided by investing activities	(28,138)	(127,212)
Cash Flows from Financing Activities
Proceeds from notes payable - related parties		3,500
Proceeds from notes payable	410,377	428,030
Proceeds from convertible notes payable	920,000	613,000
Proceeds from advances payable	1,450,000
Proceeds from sale of common stock	175,000	140,000
Proceeds from preferred series C stock subscriptions		270,000
Repayments of notes payable - related parties	(53,763)	(32,286)
Repayments of notes payable	(796,036)	(556,153)
Repayments of convertible notes payable	(673,989)	(356,888)
Net cash provided by financing activities	1,431,589	509,203
Net change in cash	124,131	93,635
Cash and cash equivalents at beginning of period	115,196	67,613
Cash and cash equivalents at end of period	239,327	161,248
Supplemental Cash Flow Information
Cash paid for interest	72,763	77,687
Cash paid for income taxes
Non-Cash Investing and Financing Activities:
Preferred series C stock deemed dividend		270,000
Original debt discounts against notes payable	174,435	95,562
Original debt discounts against convertible notes payable	12,000	201,388
Common stock issued for services	81,740
Common stock issued in conversion of convertible notes payable	149,000	939,668
Common stock issued in settlement of notes payable to related parties	653,310
Common stock issued in cashless exercise of warrants	34,594	429,948
Common stock issued in conversion of preferred series C stock	40,000	444,000
Property plant and equipment transferred to inventory		$ 26,669

NOTE 1. BASIS OF PRESENTATION A

NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The unaudited interim condensed consolidated financial statements of PCT LTD (the "Company") have been prepared in accordance with United States generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and reflect all adjustments which, in the opinion of management, are necessary for a fair presentation of our balance sheets, statements of operations, stockholders' equity (deficit), and cash flows for the periods presented. All such adjustments are of a normal recurring nature. The results of operations for the interim period are not necessarily indicative of the results to be expected for a full year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the financial statements and notes thereto included in the Company's December 31, 2020 audited financial statements as reported in its Form 10-K/A filed on September 10, 2021. COVID-19 In December 2019 COVID-19 emerged in Wuhan, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to almost all other countries, including the United States, and infections have been reported globally. Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. Additional, more restrictive proclamations and/or directives may be issued in the future. The ultimate impact of the COVID-19 pandemic on the Company's operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak. Any resulting financial impact cannot be reasonably estimated at this time but may have a material impact on our business, financial condition and results of operations. The significance of the impact of the COVID-19 outbreak on the Company's businesses and the duration for which it may have an impact cannot be determined at this time. At a minimum, the COVID-19 pandemic caused the Company to restrict travel of its personnel and to initiate distributor installations of certain of the Company's equipment, as possible. The Company adapted to the immediate need for its US EPA registered disinfectant at the end of March and beginning of April, 2020, by installing greater storage reserves and by assembling more of it higher-volume equipment to produce the hospital grade disinfectant known as Hydrolyte®. There were hard costs associated with these adaptations to the Little River, SC facility, but the Company continues to benefit from its fluid production capacities over the longer term. As the Federal, state and other restrictions associated with the pandemic have lessened, the Company is able to act more effectively in obtaining new contracts for its healthcare equipment, the Annihilyzer® and other equipment. Nature of Operations PCT LTD (formerly Bingham Canyon Corporation, (the "Company," "PCT Ltd," or "Bingham"), a Delaware corporation, was formed on February 27, 1986. The Company changed its domicile to Nevada on August 26, 1998. The Company acquires, develops and provides sustainable, environmentally safe disinfecting, cleaning and tracking technologies. The Company specializes in providing cleaning, sanitizing, and disinfectant fluid solutions and fluid-generating equipment that creates environmentally safe solutions for global sustainability. Paradigm is located in Little River, SC and was formed June 6, 2012 under the name of EUR-ECA, Ltd. On September 11, 2015, its Board of Directors authorized EUR-ECA Ltd to file with the Nevada Secretary of State to change its name to Paradigm Convergence Technologies Corp. Paradigm is a technology licensing company specializing in environmentally safe solutions for global sustainability. The company holds a patent, intellectual property and/or distribution rights to innovative products and technologies. Paradigm provides innovative products and technologies for eliminating biocidal contamination from water supplies, industrial fluids, hard surfaces, food processing equipment, and medical devices. Paradigm's overall strategy is to market new products and technologies through the use of equipment leasing, joint ventures, licensing, distributor agreements and partnerships. Effective on February 29, 2018, the Company changed its name from Bingham Canyon Corporation to PCT LTD to more accurately identify the Company's direction and to develop the complimentary relationship and association with its wholly-owned operating company, Paradigm Convergence Technologies Corporation ("Paradigm" or "PCT Corp."). Significant Accounting Policies There have been no changes to the significant accounting policies of the Company from the information provided in Note 1 of the Notes to the Consolidated Financial Statements in the Company's most recent Form 10-K. Fair Value Measurements The Company follows ASC 820, " Fair Value Measurements and Disclosures • Level 1 - Valuations for assets and liabilities traded in active markets from readily available pricing sources such as quoted prices in active markets for identical assets or liabilities. • Level 2 - Observable inputs (other than Level 1 quoted prices) such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. • Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. The carrying values of our financial instruments, including, cash and cash equivalents, accounts receivable, inventory, prepaid expenses, accounts payable and accrued expenses approximate their fair value due to the short maturities of these financial instruments. Derivative liabilities are determined based on "Level 3" inputs, which are significant and unobservable and have the lowest priority. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations. Our financial assets and liabilities carried at fair value measured on a recurring basis Total fair value at Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Description: Derivative liability (1) 1,561,420 - - 1,561,420 Total 1,561,420 - - 1,561,420 Our financial assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2020, consisted of the following: Total fair value at Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Description: Derivative liability (1) 7,102,801 - - 7,102,801 Total 7,102,801 - - 7,102,801 (1) The Company has estimated the fair value of these liabilities using the Binomial Model. Basic and Diluted Loss Per Share Basic income (loss) per share 18,902,412 Three months ended September 30, 2021 Three months ended September 30, 2020 Nine months Nine months Numerator: Net income (loss) (146,187 ) (3,805,958 ) 3,207,572 (7,338,523 ) (Gain) loss on change in fair value of derivative liability - - (1,641,616 ) - Gain on settlement of debt - - (3,792,104 ) - Interest expense - - 30,617 - Adjusted net income (loss) (146,187 ) (3,805,958 ) (2,195,531 ) (7,338,523 ) Denominator: Weighted average shares outstanding used in computing net income (loss) per share Basic 773,082,751 608,601,357 760,229,694 575,094,639 Effect of dilutive warrants - - 203,745,854 - Effect of convertible note weighted shares - - 60,456,989 - Diluted 773,082,751 608,601,357 1,024,432,537 575,094,639 Net income (loss) per share applicable to common shareholders: Basic (0.00 ) (0.01 ) (0.00 ) (0.01 ) Diluted (0.00 ) (0.01 ) (0.00 ) (0.01 ) Recent Accounting Pronouncements ASU 2019-12 amends the requirements related to the accounting for "hybrid" tax regimes. Such regimes are tax jurisdictions that impose the greater of two taxes - one based on income, or one based on items other than income. Although ASC 740 does not apply to taxes based on items other than income, ASC 740-10-15-4(a) originally specified that if there is a tax based on income that is greater than a franchise tax based on capital, only that excess is subject to the guidance in ASC 740. In feedback to the FASB, stakeholders indicated that the guidance on hybrid tax regimes increased the cost and complexity of applying ASC 740, particularly when the tax amount deemed to be a non-income tax was insignificant. Further, such guidance made it more difficult for entities to determine the appropriate tax rate to use when recording deferred taxes. Accordingly, the FASB amended ASC 740-10-15-4(a) to state that an entity should include the amount of tax based on income in the tax provision and should record any incremental amount recorded as a tax not based on income. This amendment effectively reverses the order in which an entity determines the type of tax under current U.S. GAAP. In addition, the ASU amends the illustrative examples referred to and included in ASC 740-10-55-26 and ASC 740-10-55-139 through 55-144. The FASB notes that such amendments are consistent with the accounting for other incremental taxes, such as the base erosion anti-abuse tax. Moreover, in paragraph BC12 of the ASU, the FASB concluded that subjecting these taxes to the disclosure requirements in ASC 740 will result in greater transparency of franchise tax amounts. In August 2020, the FASB issued ASU 2020-06, "Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815- 40)" ("ASU 2020-06"). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity's own equity. The ASU is part of the FASB's simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU's amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2020-06 will have on its financial statements.

NOTE 2. GOING CONCERN

NOTE 2. GOING CONCERN	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NOTE 2. GOING CONCERN	NOTE 2. GOING CONCERN The accompanying consolidated condensed financial statements have been prepared assuming that the Company will continue as a going concern. The Company has an accumulated deficit of $ 27,380,040 5,563,299

NOTE 3. PROPERTY AND EQUIPMENT

NOTE 3. PROPERTY AND EQUIPMENT	9 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
NOTE 3. PROPERTY AND EQUIPMENT	NOTE 3. PROPERTY AND EQUIPMENT Property and equipment September 30, 2021 December 31, 2020 Leasehold improvements $ 33,770 $ 18,840 Machinery and leased equipment 365,483 365,483 Machinery and equipment not yet in service 32,580 32,580 Office equipment and furniture 52,566 39,357 Website 2,760 2,760 Total property and equipment $ 487,159 $ 459,020 Less: Accumulated Depreciation (167,028 ) (100,301 ) Property and equipment, net 320,131 358,719 Depreciation expense was $ 66,726 27,085

NOTE 4. INTANGIBLE ASSETS

NOTE 4. INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
NOTE 4. INTANGIBLE ASSETS	NOTE 4. INTANGIBLE ASSETS Intangible assets September 30, 2021 December 31, 2020 Patents $ 4,505,489 $ 4,505,489 Technology rights 200,000 200,000 Intangibles, at cost 4,705,489 4,705,489 Less: Accumulated amortization (1,533,831 ) (1,305,465 ) Net Carrying Amount $ 3,171,658 $ 3,400,024 Amortization expense was $ 228,366 228,283 Estimated Future Amortization Expense $ For year ending December 31, 2021 - remaining 76,122 For year ending December 31, 2022 304,488 For year ending December 31, 2023 304,488 For year ending December 31, 2024 304,488 For year ending December 31, 2025 304,488 Thereafter 1,877,584 Total 3,171,658

NOTE 5. LEASES

NOTE 5. LEASES	9 Months Ended
	Sep. 30, 2021
Leases [Abstract]
NOTE 5. LEASES	NOTE 5. LEASES On August 26, 2020, the Company signed a new one-year lease for the Company headquarters and operations located in Little River, South Carolina. The lease was effective retroactively from July 1, 2020, ending on June 30, 2021, for $ 7,500 7,650 On October 19, 2020, the Company entered into a building lease with a three-year term and an effective date of November 1, 2020. The lease requires the Company to make payments of $ 4,500 40,500 On March 15, 2021, the Company entered into a building lease with a two-year term and an effective date of April 1, 2021. The lease requires the Company to make payments of $ 2,750 19,250 39,030 At September 30, 2021, the weighted average remaining operating lease term was 2.07 years and the weighted average discount rate associated with operating leases was 18.5%. The components of lease expenses 2021 $ 2020 $ Total operating lease cost 59,750 - The following table provides supplemental cashflow and other information related to leases for the nine-month period ended September 30, 2021 and 2020: 2021 $ 2020 $ Lease payments 127,700 40,440 Supplemental balance sheet information related to leases as of September 30, 2021 and 2020 are as below: 2021 $ 2020 $ Cost 176,213 - Accumulated amortization (44,411 ) - Impairment (39,030 ) Net carrying value 92,772 - Future minimum lease payments related to lease obligations $ 2021 13,500 2022 54,000 2023 45,000 Total minimum lease payments 112,500 Less: amount of lease payments representing effects of discounting (19,728 ) Present value of future minimum lease payments 92,772 Less: current obligations under leases (40,127 ) Lease liabilities, net of current portion 52,645

NOTE 6. NOTES PAYABLE

NOTE 6. NOTES PAYABLE	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
NOTE 6. NOTES PAYABLE	NOTE 6. NOTES PAYABLE The following tables summarize notes payable Type Original Amount Origination Date Maturity Date Effective Annual Interest Rate Balance at September 30, 2021 Balance at December 31, 2020 Note Payable (a)** $ 25,000 05/08/2017 06/30/2018 0 % $ 22,500 $ 27,500 Note Payable (b) $ 8,700 11/15/2018 06/30/2019 10 % $ - $ 8,700 Note Payable ** $ 118,644 05/05/2020 05/05/2021 8 % $ 110,644 $ 110,644 Note Payable (c) $ 199,500 10/01/2020 09/28/2021 66 % $ - $ 149,573 Note Payable (d) $ 126,000 11/03/2020 04/23/2021 166 % $ - $ 85,050 Note Payable (e) $ 113,980 11/04/2020 03/15/2021 210 % $ - $ 65,988 Note Payable (f) $ 177,800 01/02/2021 07/12/2021 116 % $ - $ - Note Payable (g) $ 111,920 03/09/2021 05/21/2021 220 % $ - $ - Note Payable (h) $ 29,686 03/09/2021 Demand 34 % $ - $ - Note Payable (i) $ 222,400 06/01/2021 Demand 181 % $ 76,985 $ - Note Payable (j) $ 87,000 06/29/2021 Demand 211 % $ 31,320 $ - Sub-total $ 241,449 $ 447,455 Debt discount $ (9,945 ) $ (63,075 ) Balance, net $ 231,504 $ 384,380 Less current portion $ (231,504 ) $ (384,380 ) Total long-term $ - $ - ** Currently in default a) On July 19, 2021, the Company repaid the principal amount of $ 5,000 22,500 b) On July 19, 2021, the Company repaid the principal amount of $ 8,700 0 c) On October 1, 2020, the Company sold future receivables with a non-related party for $ 199,500 53,250 146,250 3,841 30,642 0 d) On November 3, 2020, the Company sold future receivables with a non-related party for $ 126,000 39,650 86,350 1,050 18,944 85,050 0 e) On November 4, 2020, the Company sold future receivables with a non-related party for $ 113,980 , of which $ 34,440 was loan fees and original issue discount resulting in cash proceeds to the Company of $ 79,540 . The advance is to be repaid through $ 5,999 weekly payments. In connection with the advance, the Company granted the lender a security interest and all past, present and future assets of the Company. During the nine months ended September 30, 2021, $ 13,489 of the discount was amortized to expense, and the remaining $ 65,988 was repaid leaving a note balance of $ 0 . f) On January 2, 2021, the Company sold future receivables with a non-related party for $ 177,800 39,795 35,994 102,011 7,730 39,795 46,383 43,600 2,783 0 g) On March 9, 2021, the Company sold future receivables with a non-related party for $ 111,920 35,120 76,800 1,399 35,120 111,920 0 h) On March 9, 2021, the Company sold future receivables with a non-related party for $ 29,686 10,120 19,566 10,120 29,686 0 i) On June 1, 2021, the Company sold future receivables with a non-related party for $ 222,400 8,000 62,400 152,000 8,554 64,414 145,415 70,999 5,986 j) On June 29, 2021, the Company sold future receivables with a non-related party for $ 87,000 27,000 60,000 23,041 55,680 27,361 3,959 The following table summarizes notes payable, related parties Type Original Amount Origination Date Maturity Date Annual Interest Rate Balance at September 30, 2021 Balance at December 31, 2020 Note Payable, RP (k) $ 30,000 04/10/2018 01/15/2019 3 % $ - $ 30,000 Note Payable, RP (l) $ 380,000 06/20/2018 01/02/2020 8 % $ - $ 380,000 Note Payable, RP (m) $ 350,000 06/20/2018 01/02/2020 5 % $ - $ 285,214 Note Payable, RP (n)** $ 17,000 06/20/2018 01/02/2020 5 % $ 15,000 $ 17,000 Note Payable, RP ** $ 50,000 07/27/2018 11/30/2018 8 % $ 50,000 $ 50,000 Note Payable, RP (o) $ 5,000 10/09/2018 Demand 0 % $ - $ 5,000 Note Payable, RP (p) $ 5,000 10/19/2018 Demand 0 % $ 4,237 $ 5,000 Note Payable, RP ** $ 15,000 08/16/2019 02/16/2020 8 % $ 15,000 $ 15,000 Note Payable, RP (q) $ 2,000 02/11/2020 Demand 0 % $ - $ 2,000 Note Payable, RP (m) $ 84,034 02/16/2021 Demand 5 % $ 70,034 $ - Subtotal $ 154,271 $ 789,214 Debt discount $ - $ - Balance, net $ 154,271 $ 789,214 Less current portion $ (154,271 ) $ (789,214 ) Total long-term $ - $ - ** Currently in default k) During the nine-months ended September 30, 2021, the Company made several payments to repay the principal amount of $ 30,000 0 l) On February 16, 2021, the Company issued 2,663,299 380,000 26,153 74,572 328,919 m) On February 16, 2021, the Company issued 1,803,279 247,270 275,000 331,304 84,034 5 50,492 194,861 14,000 70,034 n) On July 15, 2021, the Company repaid the principal amount of $ 2,000 15,000 o) On September 23, 2021, the Company repaid the principal amount of $ 5,000 0 p) On September 23, 2021, the Company repaid the principal amount of $ 763 4,237 q) On September 23, 2021, the Company repaid the principal amount of $ 2,000 0 The following table summarizes convertible notes payable Type Original Amount Origination Date Maturity Date Annual Interest Rate Balance at September 30, 2021 Balance at December 31, 2020 Convertible Note Payable* ** $ 65,000 12/06/2018 12/06/2019 12 % $ 46 $ 46 Convertible Note Payable (r) $ 75,000 03/18/2019 12/13/2019 24 % $ - $ 177,795 Convertible Note Payable (s) $ 30,000 03/06/2020 03/05/2021 12 % $ - $ 21,662 Convertible Note Payable (t)* ** $ 150,000 04/10/2020 04/09/2021 12 % $ 65,000 $ 165,000 Convertible Note Payable (u) ** $ 300,000 08/27/2020 07/31/2021 12 % $ 270,000 $ 300,000 Convertible Note Payable (v) $ 53,500 09/22/2020 03/21/2022 12 % $ - $ 53,500 Convertible Note Payable (w) $ 87,500 09/24/2020 Demand 8 % $ 15,000 $ 40,000 Convertible Note Payable (x) $ 200,000 10/07/2020 10/06/2021 5 % $ 200,000 $ 200,000 Convertible Note Payable (y) $ 200,000 10/16/2020 10/15/2021 5 % $ 200,000 $ 200,000 Convertible Note Payable (z) $ 300,000 11/11/2020 11/10/2021 5 % $ 300,000 $ 300,000 Convertible Note Payable (aa) $ 150,000 12/29/2020 12/28/2021 5 % $ 150,000 $ 150,000 Convertible Note Payable (bb) $ 150,000 01/27/2021 01/27/2022 5 % $ 150,000 $ - Convertible Note Payable (cc) $ 128,000 02/22/2021 02/22/2022 12 % $ - $ - Convertible Note Payable (dd) $ 200,000 03/18/2021 03/18/2022 5 % $ 200,000 $ - Convertible Note Payable (ee) $ 83,000 03/26/2021 03/26/2022 12 % $ - $ - Convertible Note Payable (ff) $ 43,000 04/05/2021 04/05/2022 12 % $ - $ - Convertible Note Payable (gg) $ 200,000 04/14/2021 04/14/2022 5 % $ 200,000 $ - Convertible Note Payable (hh) $ 128,000 05/03/2021 05/03/2022 12 % $ 128,000 $ - Subtotal $ 1,876,046 $ 1,608,003 Debt discount $ (1,708 ) $ - Balance, net $ 1,876,338 $ 1,608,003 Less current portion $ (1,876,338 ) $ (1,554,503 ) Total long-term - 53,500 * Embedded conversion feature accounted for as a derivative liability at period end r) During the nine months ended September 30, 2021, the Company repaid $ 70,000 40,000 8,000,000 124,000 20,364 s) On May 7, 2021, the Company deemed in the best interest to settle the convertible debt with a non-related party and allow for the cashless exercise to purchase 1,921,875 0.032 60,072,853 36,994 15,174 36,836 3,657 36,994 1,921,875 34,594 31,095 t) On April 10, 2020, the Company entered into a convertible promissory note with a non-related party for $ 150,000 18,000 132,000 12 The embedded conversion option qualified for derivative accounting and bifurcation under ASC 815-15. The initial fair value of the conversion feature was $ 507,847 132,000 375,847 15,000 165,000 100,000 65,000 u) During the nine months ended September 30, 2021, the Company repaid $ 30,000 270,000 v) On September 22, 2020, the Company entered into a convertible promissory note with a non-related party for $ 53,500 3,500 50,000 12 53,500 25,882 w) During the nine months ended September 30, 2021 the Company issued 25,000,000 25,000 15,000 15,000,000 15,000 x) On October 7, 2020, the Company entered into a convertible promissory note with a non-related party for $ 200,000 5 y) On October 16, 2020, the Company entered into a convertible promissory note with a non-related party for $ 200,000 5 z) On November 11, 2020, the Company entered into a convertible promissory note with a non-related party for $ 300,000 5 aa) On December 29, 2020, the Company entered into a convertible promissory note with a non-related party for $ 150,000 5 bb) On January 27, 2021, the Company entered into a convertible promissory note with a non-related party for $ 150,000 5 cc) On February 22, 2021, the Company entered into a convertible promissory note with a non-related party for $ 128,000 3,000 125,000 12 128,000 51,000 dd) On March 18, 2021, the Company entered into a convertible promissory note with a non-related party for $ 200,000 5 ee) On March 26, 2021, the Company entered into a convertible promissory note with a non-related party for $ 83,000 3,000 80,000 12 83,000 39,694 ff) On April 5, 2021, the Company entered into a convertible promissory note with a non-related party for $ 43,000 3,000 40,000 12 43,000 12,270 gg) On April 14, 2021, the Company entered into a convertible promissory note with a non-related party for $ 200,000 5 hh) On May 3, 2021, the Company entered into a convertible promissory note with a non-related party for $ 128,000 3,000 125,000 12 128,000 61,952

NOTE 7. DERIVATIVE LIABILITIES

NOTE 7. DERIVATIVE LIABILITIES	9 Months Ended
	Sep. 30, 2021
Note 7. Derivative Liabilities
NOTE 7. DERIVATIVE LIABILITIES	NOTE 7. DERIVATIVE LIABILITIES The embedded conversion option of (1) the convertible notes payable described in Note 5; (2) warrants; contain conversion features that qualify for embedded derivative classification. The fair value of the liabilities will be re-measured at the end of every reporting period and the change in fair value will be reported in the statement of operations as a gain or loss on derivative financial instruments. Upon the issuance of the convertible notes payable described in Note 6, the Company concluded that it only has sufficient shares to satisfy the conversion of some but not all of the outstanding convertible notes, warrants and options. The Company elected to reclassify contracts from equity with the earliest inception date first. As a result, none of the Company's previously outstanding convertible instruments qualified for derivative reclassification, however, any convertible securities issued after the election, including the warrants described in Note 10, qualified for derivative classification. The Company reassesses the classification of the instruments at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. The table below sets forth a summary of changes in the fair value of the Company's Level 3 financial liabilities September 30, December 31, Balance at the beginning of period $ 7,102,801 $ 10,517,873 Original discount limited to proceeds of notes - 166,000 Settlement of derivative instruments (3,792,104 ) (16,824,669 ) Change in fair value of embedded conversion option (1,749,277 ) 13,243,597 Balance at the end of the period $ 1,561,420 $ 7,102,801 The Company uses Level 3 inputs for its valuation methodology for the embedded conversion option and warrant liabilities as their fair values were determined by using the Binomial Model based on various assumptions. Significant changes in any of these inputs in isolation would result in a significant change in the fair value measurement. As required, these are classified based on the lowest level of input that is significant to the fair value measurement. The following table shows the assumptions used in the calculations Expected Volatility Risk-free Interest Rate Expected Dividend Yield Expected Life (in years) At September 30, 2021 113 249 % 0.09 0.76 % 0 % 1.00 3.91 The Company uses Level 3 inputs for its valuation methodology for the preferred series A stock liability as their fair values were determined by using the Binomial Model based on various assumptions.

NOTE 8. STOCKHOLDERS' DEFICIT

NOTE 8. STOCKHOLDERS' DEFICIT	9 Months Ended
	Sep. 30, 2021
Equity [Abstract]
NOTE 8. STOCKHOLDERS' DEFICIT	NOTE 8. STOCKHOLDERS' DEFICIT Preferred Stock Effective March 23, 2018, the Company amended the articles of incorporation and authorized 10,000,000 0.001 Series A Preferred Shares Effective March 23, 2018, the Company amended the articles of incorporation and authorized 10,000,000 0.001 1,000,000 On December 1, 2018, the Company's Board of Directors authorized an offering for 1,000,000 0.10 60,000 600,000 On April 12, 2019, the Company filed a Certificate of Designation with the Nevada Secretary of State designating 1,000,000 Issue Price The stated price for the Series A Preferred shall be $0.10 per share. Redemption This Company may at any time following the first anniversary date of issuance (the "Redemption Date"), at the option of the Board of Directors, redeem in whole or in part the Shares by paying in cash in exchange for the Shares to be redeemed a price equal to the Original Series A Issue Price ($0.10) (the "Redemption Price"). Any redemption affected pursuant to this provision shall be made on a pro rata basis among the holders of the Shares in proportion to the number of the shares then held by them. Dividends None. Preference of Liquidation In the event of any liquidation, dissolution or winding up of the Company, the holders of Shares shall be entitled to receive, prior and in preference to any distribution of any of the assets of this Company, to the holders of Common Stock by reason of their ownership thereof, an amount per share equal to the sum of (i) $0.10 for each outstanding Share (the "Original Series A Issue Price") and (ii) an amount equal to 6% of the Original Series A Issue Price for each 12 months that has passed since the date of issuance of any Shares (such amount being referred to herein as the "Premium"). For purposes of this provision, a liquidation, dissolution or winding up of this Company shall be deemed to be occasioned by, or to include, (A) the acquisition of the Company by another entity by means of any transaction or series of related transactions (including, without limitation, any reorganization, merger or consolidation but, excluding any merger effected exclusively for the purpose of changing the domicile of the Company); or (B) a sale of all or substantially all of the assets of the Company; unless the Company's stockholders of record as constituted immediately prior to such acquisition or sale will, immediately after such acquisition or sale (by virtue of securities issued as consideration for the Company's acquisition or sale or otherwise), hold at least 50% of the voting power of the surviving or acquiring entity. If upon the occurrence of such liquidation, dissolution or winding up event, the assets and funds thus distributed among the holders of the Shares shall be insufficient to permit the payment to such holders of the full aforesaid preferential amounts, then, subject to the rights of series of preferred stock that may from time to time come into existence, the entire assets and funds of the Company legally available for distribution shall be distributed ratably among the holders of the Shares in proportion to the preferential amount each such holder is otherwise entitled to receive. In any of such liquidation, dissolution or winding up event, if the consideration received by the Company is other than cash, its value will be deemed its fair market value. Any securities shall be valued as follows: A. Securities not subject to investment letter or other similar restrictions on free marketability (covered by (B) below): 1) If traded on a securities exchange (NASDAQ, AMEX, NYSE, etc.), the value shall be deemed to be the average of the closing prices of the securities on such exchange over the thirty-day period ending three (3) days prior to the closing; 2) If traded on a quotation system, such as the OTC:QX, OTC:QB or OTC Pink Sheets, the value shall be deemed to be the average of the closing bid or sale prices (whichever is applicable) over the thirty-day period ending three (3) days prior to the closing; and 3) If there is no active public market, the value shall be the fair market value thereof, as mutually determined by the Company and the holders of at least a majority of the voting power of all then outstanding shares of Preferred Stock. B. The method of valuation of securities subject to investment letter or other restrictions on free marketability (other than restrictions arising solely by virtue of a stockholder's status as an affiliate or former affiliate) shall be to make an appropriate discount from the market value determined as above in (A) (1), (2) or (3) to reflect the approximate fair market value thereof, as mutually determined by the Company and the holders of at least a majority of the voting power of all then outstanding shares of such Preferred Stock: Voting The holder of each Share shall not have any voting rights, except in the case of voting on a change in the preferences of Shares. Conversion Each Share shall be convertible into shares of the Company's Common Stock at a price per share of $0.10 (1 Share converts into 1 share of Common Stock), at the option of the holder thereof, at any time following the date of issuance of such Share and on or prior to the fifth day prior to the Redemption Date, if any, as may have been fixed in any Redemption Notice with respect to the Shares, at the office of this Company or any transfer agent for such stock. Each Share shall automatically be converted into shares of Common Stock on the first day of the thirty-sixth (36th) month following the original issue date of the shares at the Conversion Price per share. The Company was unable to issue the subscribers the preferred shares until the Company filed a Certificate of Designation and the Preferred Series "A" stock had been duly validly authorized. As the Company had not filed the Certificate of Designation and as the Company could not issue the preferred shares to settle the proceeds received, it was determined the subscriptions were settleable in cash. As a result, the Company classified the subscriptions received as a liability in accordance with ASC 480 Distinguishing Liabilities from Equity. The filing of the Certificate of Designation and issuance of the preferred shares resulted in the reclassification of the Series A Preferred Shares from a liability to temporary equity or "mezzanine" because the preferred shares include the liquidation preferences described above. The fair value of the preferred series A stock on April 12, 2019 was $60,398 and was valued by using the Binomial Model based on various assumptions and was reclassified from a liability to mezzanine equity. As of September 30, 2021, and December 31, 2020, there were 500,000 Series B Preferred Shares Effective August 13, 2019, the Company filed a Certificate of Designation with the Nevada Secretary of State thereby designating 1,000,000 Voting Rights Holders of the Series B Preferred Stock shall be entitled to cast five hundred (500) votes for each share held of the Series B Preferred Stock on all matters presented to the stockholders of the Corporation for stockholder vote which shall vote along with holders of the Corporation's Common Stock on such matters. Redemption Rights The Series B Preferred Stock shall be redeemed by the Corporation upon the successful receipt by the Corporation of at least $1,000,000 in equity capital following the issuance of the Series B Preferred Stock. To date the Company has received $500,500 of equity capital, and upon the receipt of an additional $499,500 in equity capital the redemption right will be triggered. Conversion Rights The Series B Preferred Stock is not convertible into shares of Common Stock of the Corporation. Protective Provisions So long as any shares of Series B Preferred Stock are outstanding, this Corporation shall not without first obtaining the approval (by vote or written consent, as provided by law) of the Holders of the Series B Preferred Stock which is entitled, other than solely by law, to vote with respect to the matter, and which Preferred Stock represents at least a majority of the voting power of the then outstanding shares of such Series B Preferred Stock: a) sell, convey, or otherwise dispose of or encumber all or substantially all of its property or business or merge into or consolidate with any other corporation (other than a wholly owned subsidiary corporation) or effect any transaction or series of related transactions in which more than fifty percent (50%) of the voting power of the Corporation is disposed of; b) alter or change the rights, preferences or privileges of the shares of Series B Preferred Stock so as to affect adversely the shares; c) increase or decrease (other than by redemption or conversion) the total number of authorized shares of preferred stock; d) authorize or issue, or obligate itself to issue, any other equity security, including any other security convertible into or exercisable for any equity security (i) having a preference over, or being on a parity with, the Series B Preferred Stock with respect to dividends or upon liquidation, or (ii) having rights similar to any of the rights of the Series B Preferred Stock; or e) amend the Corporation's Articles of Incorporation or bylaws. Dividends None. Preference of Liquidation None Upon designation, the Company issued 500,000 1,000,000 158,247 As of September 30, 2021, and December 31, 2020, there were 1,000,000 Series C Preferred Shares Pursuant to the September 18, 2019 majority consent of stockholders in lieu of an annual meeting (including the consent of the Series A Convertible Preferred Stockholders), the Registrant filed a Certificate of Designation with the Nevada Secretary of State designating 5,500,000 The number of shares constituting the Series C Convertible Preferred Stock shall be 5,500,000 Conversion Rights Each Share shall be convertible into shares of the Company's Common Stock at a price per share of $0.01 (1 Share converts into 100 shares of Common Stock) (the "Conversion Price"), at the option of the holder thereof, at any time following the date of issuance of such Share and on or prior to the fifth (5th) day prior to the redemption Date, if any, as may have been fixed in any redemption notice with respect to the Shares, at the office of this Company or any transfer agent for such stock. Voting Rights The holder of each Share shall not have any voting rights, except in the case of voting on a change in the preferences of Shares. Protective Provisions So long as any Shares are outstanding, this Company shall not without first obtaining the approval (by vote or written consent, as provided by law) of the holders of Shares which is entitled, other than solely by law, to vote with respect to the matter, and which Shares represents at least a majority of the voting power of the then outstanding Shares: a) sell, convey, or otherwise dispose of or encumber all or substantially all of its property or business or merge into or consolidate with any other corporation (other than a wholly owned subsidiary corporation) or effect any transaction or series of related transactions in which more than fifty percent (50%) of the voting power of the Company is disposed of; b) alter or change the rights, preferences or privileges of the Shares so as to affect adversely the Shares; c) increase or decrease (other than by redemption or conversion) the total number of authorized shares of preferred stock; d) authorize or issue, or obligate itself to issue, any other equity security, including any other security convertible into or exercisable for any equity security (i) having a preference over, or being on a parity with, the Shares with respect to liquidation, or (ii) having rights similar to any of the rights of the Preferred Stock; or e) amend the Company's Articles of Incorporation or bylaws. Other Rights There are no other rights, privileges or preferences attendant or relating to in any way the Shares, including by way of illustration but not limitation, those concerning dividend, ranking, other conversion, other redemption, participation or anti-dilution rights or preferences. As conversion of the Series C Preferred Shares is not within the control of the Company, and it is not certain that the Company could satisfy its obligation to deliver shares upon conversion, the Series C Preferred Shares were classified in temporary equity or "mezzanine". At December 31, 2020, there were 40,000 1 40,000 On February 15, 2021, 40,000 4,000,000 Common Stock Effective March 23, 2018, the Company amended the Articles of Incorporation and increased the authorized shares of common stock with a par value of $ 0.001 100,000,000 300,000,000 0.001 300,000,000 1,000,000,000 780,126,229 722,487,846 On January 4, 2021, the Company issued 25,000,000 40,000 On February 15, 2021, 40,000 4,000,000 On February 16, 2021, the Company issued 1,803,279 247,270 275,000 331,304 On February 16, 2021, the Company issued 2,663,299 380,000 26,153 On March 1, 2021, the Company entered into a consulting agreement. Pursuant to the agreement, the consultant will provide advisory services through May 31, 2021 in consideration of 2,500,000 62,750 On May 7, 2021, the Company issued 1,921,875 On May 27, 2021, the Company issued 1,000,000 18,990 On June 2, 2021, the Company issued 3,750,000 75,000 On June 30, 2021, the Company issued 5,000,000 100,000 On September 1, 2021, the Company issued 8,000,000 21,000 88,795 26,153 20,364 On September 10, 2021, the Company issued 2,000,000 28,400

NOTE 9. STOCK OPTIONS

NOTE 9. STOCK OPTIONS	9 Months Ended
	Sep. 30, 2021
Note 9. Stock Options
NOTE 9. STOCK OPTIONS	NOTE 9. STOCK OPTIONS Below is a table summarizing the options issued and outstanding Number of Weighted average exercise price Balance, December 31, 2020 200,000 2.00 Granted - - Expired - - Settled - - Balance, September 30, 2021 200,000 2.00 As at September 30, 2021, the following share stock options were outstanding Date Number Number Exercise Weighted Average Remaining Contractual Expiration Proceeds to Company if Issued Outstanding Exercisable Price $ Life (Years) Date Exercised 01/26/2017 200,000 200,000 2.00 0.32 01/26/2022 400,000 200,000 200,000 $ 400,000 The weighted average exercise prices are $2.00 for the options outstanding and exercisable, respectively. The intrinsic value of stock options outstanding at September 30, 2021 was $nil.

NOTE 10. WARRANTS

NOTE 10. WARRANTS	9 Months Ended
	Sep. 30, 2021
Note 10. Warrants
NOTE 10. WARRANTS	NOTE 10. WARRANTS The Company concluded that it only has sufficient shares to satisfy the conversion of some but not all of the outstanding convertible instruments. The initial fair value of the warrants issued during the period was calculated using the Binomial Model as described in Note 6. The following table summarizes the continuity of share purchase warrants Number of Weighted average exercise price Balance, December 31, 2020 260,500,000 0.00283 Settled - - Granted - - Exercised (142,857,143 ) 0.00035 Balance, September 30, 2021 117,642,857 0.00584 As at September 30, 2021, the following share purchase warrants were outstanding Date Number Number Exercise Weighted Average Remaining Contractual Expiration Proceeds to Company if Issued Outstanding Exercisable Price $ Life (Years) Date Exercised 12/3/2018 500,000 500,000 0.10 2.18 12/3/2023 50,000 3/31/2019 107,142,857 107,142,857 * 0.00035 * 2.45 03/13/2024 37,500 8/26/2020 10,000,000 * 10,000,000 * 0.06 * 3.91 8/26/2025 600,000 117,642,857 117,642,857 $ 687,500 *The number of warrants outstanding and exercisable is variable based on adjustments to the exercise price of the warrant due to dilutive issuances. The intrinsic value of warrants outstanding at September 30, 2021 was $ 1,237,500

NOTE 11. RELATED PARTY TRANSACT

NOTE 11. RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
NOTE 11. RELATED PARTY TRANSACTIONS	NOTE 11. RELATED PARTY TRANSACTIONS The Company has agreements with related parties for consulting services, accrued rent, accrued interest, notes payable and stock options. See Notes to Financial Statements numbers 6, 8, 9 and 11 for more details.

NOTE 12. COMMITMENTS AND CONTIN

NOTE 12. COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
NOTE 12. COMMITMENTS AND CONTINGENCIES	NOTE 12. COMMITMENTS AND CONTINGENCIES Consulting Agreements On March 1, 2021, the Company entered into a consulting agreement. Pursuant to the agreement, the consultant will provide consulting services to the Company in various marketing and management matters for a period of three months. In consideration for the services performed by the consultant, the Company agreed to compensate the consultant $5,000 per month. The Company also uses the professional services of securities attorneys, a US EPA specialist, professional accountants and other public-company specialists. Employment Agreements - On May 5, 2021, the Company entered into an employment agreement with a recently appointed officer, for an initial term of three years. The terms of the contract call for an annual salary of $ 70,000 1,000,000 18,990 Other Obligations and Commitments - The Company has a commitment to acquire inventory for a total cost of $ 61,150 30,575 Other than the above, there are no new obligation or commitments during the period ending September 30, 2021.

NOTE 13. SUBSEQUENT EVENTS

NOTE 13. SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
NOTE 13. SUBSEQUENT EVENTS	NOTE 13. SUBSEQUENT EVENTS a) On October 11, 2011, the Company issued 15,000,000 common shares upon the conversion of the remaining $15,000 of the convertible note payable, leaving a note balance of $0. Refer to Note 6(w). b) Effective October 14, 2021, the Company terminated a building lease with an original expiry date of March 31, 2023. Refer to Note 5. 3) On November 5, 2021, the Company repaid a $128,000 convertible note as well as $61,952 of interest and prepayment penalties. Refer to Note 6(hh).

NOTE 1. BASIS OF PRESENTATION_2

NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
COVID-19	COVID-19 In December 2019 COVID-19 emerged in Wuhan, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to almost all other countries, including the United States, and infections have been reported globally. Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. Additional, more restrictive proclamations and/or directives may be issued in the future. The ultimate impact of the COVID-19 pandemic on the Company's operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak. Any resulting financial impact cannot be reasonably estimated at this time but may have a material impact on our business, financial condition and results of operations. The significance of the impact of the COVID-19 outbreak on the Company's businesses and the duration for which it may have an impact cannot be determined at this time. At a minimum, the COVID-19 pandemic caused the Company to restrict travel of its personnel and to initiate distributor installations of certain of the Company's equipment, as possible. The Company adapted to the immediate need for its US EPA registered disinfectant at the end of March and beginning of April, 2020, by installing greater storage reserves and by assembling more of it higher-volume equipment to produce the hospital grade disinfectant known as Hydrolyte®. There were hard costs associated with these adaptations to the Little River, SC facility, but the Company continues to benefit from its fluid production capacities over the longer term. As the Federal, state and other restrictions associated with the pandemic have lessened, the Company is able to act more effectively in obtaining new contracts for its healthcare equipment, the Annihilyzer® and other equipment.
Nature of Operations	Nature of Operations PCT LTD (formerly Bingham Canyon Corporation, (the "Company," "PCT Ltd," or "Bingham"), a Delaware corporation, was formed on February 27, 1986. The Company changed its domicile to Nevada on August 26, 1998. The Company acquires, develops and provides sustainable, environmentally safe disinfecting, cleaning and tracking technologies. The Company specializes in providing cleaning, sanitizing, and disinfectant fluid solutions and fluid-generating equipment that creates environmentally safe solutions for global sustainability. Paradigm is located in Little River, SC and was formed June 6, 2012 under the name of EUR-ECA, Ltd. On September 11, 2015, its Board of Directors authorized EUR-ECA Ltd to file with the Nevada Secretary of State to change its name to Paradigm Convergence Technologies Corp. Paradigm is a technology licensing company specializing in environmentally safe solutions for global sustainability. The company holds a patent, intellectual property and/or distribution rights to innovative products and technologies. Paradigm provides innovative products and technologies for eliminating biocidal contamination from water supplies, industrial fluids, hard surfaces, food processing equipment, and medical devices. Paradigm's overall strategy is to market new products and technologies through the use of equipment leasing, joint ventures, licensing, distributor agreements and partnerships. Effective on February 29, 2018, the Company changed its name from Bingham Canyon Corporation to PCT LTD to more accurately identify the Company's direction and to develop the complimentary relationship and association with its wholly-owned operating company, Paradigm Convergence Technologies Corporation ("Paradigm" or "PCT Corp.").
Significant Accounting Policies	Significant Accounting Policies There have been no changes to the significant accounting policies of the Company from the information provided in Note 1 of the Notes to the Consolidated Financial Statements in the Company's most recent Form 10-K.
Fair Value Measurements	Fair Value Measurements The Company follows ASC 820, " Fair Value Measurements and Disclosures • Level 1 - Valuations for assets and liabilities traded in active markets from readily available pricing sources such as quoted prices in active markets for identical assets or liabilities. • Level 2 - Observable inputs (other than Level 1 quoted prices) such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. • Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. The carrying values of our financial instruments, including, cash and cash equivalents, accounts receivable, inventory, prepaid expenses, accounts payable and accrued expenses approximate their fair value due to the short maturities of these financial instruments. Derivative liabilities are determined based on "Level 3" inputs, which are significant and unobservable and have the lowest priority. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations. Our financial assets and liabilities carried at fair value measured on a recurring basis Total fair value at Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Description: Derivative liability (1) 1,561,420 - - 1,561,420 Total 1,561,420 - - 1,561,420 Our financial assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2020, consisted of the following: Total fair value at Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Description: Derivative liability (1) 7,102,801 - - 7,102,801 Total 7,102,801 - - 7,102,801 (1) The Company has estimated the fair value of these liabilities using the Binomial Model.
Basic and Diluted Loss Per Share	Basic and Diluted Loss Per Share Basic income (loss) per share 18,902,412 Three months ended September 30, 2021 Three months ended September 30, 2020 Nine months Nine months Numerator: Net income (loss) (146,187 ) (3,805,958 ) 3,207,572 (7,338,523 ) (Gain) loss on change in fair value of derivative liability - - (1,641,616 ) - Gain on settlement of debt - - (3,792,104 ) - Interest expense - - 30,617 - Adjusted net income (loss) (146,187 ) (3,805,958 ) (2,195,531 ) (7,338,523 ) Denominator: Weighted average shares outstanding used in computing net income (loss) per share Basic 773,082,751 608,601,357 760,229,694 575,094,639 Effect of dilutive warrants - - 203,745,854 - Effect of convertible note weighted shares - - 60,456,989 - Diluted 773,082,751 608,601,357 1,024,432,537 575,094,639 Net income (loss) per share applicable to common shareholders: Basic (0.00 ) (0.01 ) (0.00 ) (0.01 ) Diluted (0.00 ) (0.01 ) (0.00 ) (0.01 )
Recent Accounting Pronouncements	Recent Accounting Pronouncements ASU 2019-12 amends the requirements related to the accounting for "hybrid" tax regimes. Such regimes are tax jurisdictions that impose the greater of two taxes - one based on income, or one based on items other than income. Although ASC 740 does not apply to taxes based on items other than income, ASC 740-10-15-4(a) originally specified that if there is a tax based on income that is greater than a franchise tax based on capital, only that excess is subject to the guidance in ASC 740. In feedback to the FASB, stakeholders indicated that the guidance on hybrid tax regimes increased the cost and complexity of applying ASC 740, particularly when the tax amount deemed to be a non-income tax was insignificant. Further, such guidance made it more difficult for entities to determine the appropriate tax rate to use when recording deferred taxes. Accordingly, the FASB amended ASC 740-10-15-4(a) to state that an entity should include the amount of tax based on income in the tax provision and should record any incremental amount recorded as a tax not based on income. This amendment effectively reverses the order in which an entity determines the type of tax under current U.S. GAAP. In addition, the ASU amends the illustrative examples referred to and included in ASC 740-10-55-26 and ASC 740-10-55-139 through 55-144. The FASB notes that such amendments are consistent with the accounting for other incremental taxes, such as the base erosion anti-abuse tax. Moreover, in paragraph BC12 of the ASU, the FASB concluded that subjecting these taxes to the disclosure requirements in ASC 740 will result in greater transparency of franchise tax amounts. In August 2020, the FASB issued ASU 2020-06, "Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815- 40)" ("ASU 2020-06"). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity's own equity. The ASU is part of the FASB's simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. The ASU's amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2020-06 will have on its financial statements.

NOTE 1. BASIS OF PRESENTATION_3

NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
financial assets and liabilities carried at fair value measured on a recurring basis	Our financial assets and liabilities carried at fair value measured on a recurring basis Total fair value at Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Description: Derivative liability (1) 1,561,420 - - 1,561,420 Total 1,561,420 - - 1,561,420 Our financial assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2020, consisted of the following: Total fair value at Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Description: Derivative liability (1) 7,102,801 - - 7,102,801 Total 7,102,801 - - 7,102,801
Basic income (loss) per share	Basic income (loss) per share 18,902,412 Three months ended September 30, 2021 Three months ended September 30, 2020 Nine months Nine months Numerator: Net income (loss) (146,187 ) (3,805,958 ) 3,207,572 (7,338,523 ) (Gain) loss on change in fair value of derivative liability - - (1,641,616 ) - Gain on settlement of debt - - (3,792,104 ) - Interest expense - - 30,617 - Adjusted net income (loss) (146,187 ) (3,805,958 ) (2,195,531 ) (7,338,523 ) Denominator: Weighted average shares outstanding used in computing net income (loss) per share Basic 773,082,751 608,601,357 760,229,694 575,094,639 Effect of dilutive warrants - - 203,745,854 - Effect of convertible note weighted shares - - 60,456,989 - Diluted 773,082,751 608,601,357 1,024,432,537 575,094,639 Net income (loss) per share applicable to common shareholders: Basic (0.00 ) (0.01 ) (0.00 ) (0.01 ) Diluted (0.00 ) (0.01 ) (0.00 ) (0.01 )

NOTE 3. PROPERTY AND EQUIPMENT

NOTE 3. PROPERTY AND EQUIPMENT (Tables)	9 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Property and equipment	Property and equipment September 30, 2021 December 31, 2020 Leasehold improvements $ 33,770 $ 18,840 Machinery and leased equipment 365,483 365,483 Machinery and equipment not yet in service 32,580 32,580 Office equipment and furniture 52,566 39,357 Website 2,760 2,760 Total property and equipment $ 487,159 $ 459,020 Less: Accumulated Depreciation (167,028 ) (100,301 ) Property and equipment, net 320,131 358,719

NOTE 4. INTANGIBLE ASSETS (Tabl

NOTE 4. INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible assets	Intangible assets September 30, 2021 December 31, 2020 Patents $ 4,505,489 $ 4,505,489 Technology rights 200,000 200,000 Intangibles, at cost 4,705,489 4,705,489 Less: Accumulated amortization (1,533,831 ) (1,305,465 ) Net Carrying Amount $ 3,171,658 $ 3,400,024
Estimated Future Amortization Expense	Estimated Future Amortization Expense $ For year ending December 31, 2021 - remaining 76,122 For year ending December 31, 2022 304,488 For year ending December 31, 2023 304,488 For year ending December 31, 2024 304,488 For year ending December 31, 2025 304,488 Thereafter 1,877,584 Total 3,171,658

NOTE 5. LEASES (Tables)

NOTE 5. LEASES (Tables)	9 Months Ended
	Sep. 30, 2021
Leases [Abstract]
components of lease expenses	The components of lease expenses 2021 $ 2020 $ Total operating lease cost 59,750 - The following table provides supplemental cashflow and other information related to leases for the nine-month period ended September 30, 2021 and 2020: 2021 $ 2020 $ Lease payments 127,700 40,440 Supplemental balance sheet information related to leases as of September 30, 2021 and 2020 are as below: 2021 $ 2020 $ Cost 176,213 - Accumulated amortization (44,411 ) - Impairment (39,030 ) Net carrying value 92,772 -
Future minimum lease payments related to lease obligations	Future minimum lease payments related to lease obligations $ 2021 13,500 2022 54,000 2023 45,000 Total minimum lease payments 112,500 Less: amount of lease payments representing effects of discounting (19,728 ) Present value of future minimum lease payments 92,772 Less: current obligations under leases (40,127 ) Lease liabilities, net of current portion 52,645

NOTE 6. NOTES PAYABLE (Tables)

NOTE 6. NOTES PAYABLE (Tables)	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
notes payable	The following tables summarize notes payable Type Original Amount Origination Date Maturity Date Effective Annual Interest Rate Balance at September 30, 2021 Balance at December 31, 2020 Note Payable (a)** $ 25,000 05/08/2017 06/30/2018 0 % $ 22,500 $ 27,500 Note Payable (b) $ 8,700 11/15/2018 06/30/2019 10 % $ - $ 8,700 Note Payable ** $ 118,644 05/05/2020 05/05/2021 8 % $ 110,644 $ 110,644 Note Payable (c) $ 199,500 10/01/2020 09/28/2021 66 % $ - $ 149,573 Note Payable (d) $ 126,000 11/03/2020 04/23/2021 166 % $ - $ 85,050 Note Payable (e) $ 113,980 11/04/2020 03/15/2021 210 % $ - $ 65,988 Note Payable (f) $ 177,800 01/02/2021 07/12/2021 116 % $ - $ - Note Payable (g) $ 111,920 03/09/2021 05/21/2021 220 % $ - $ - Note Payable (h) $ 29,686 03/09/2021 Demand 34 % $ - $ - Note Payable (i) $ 222,400 06/01/2021 Demand 181 % $ 76,985 $ - Note Payable (j) $ 87,000 06/29/2021 Demand 211 % $ 31,320 $ - Sub-total $ 241,449 $ 447,455 Debt discount $ (9,945 ) $ (63,075 ) Balance, net $ 231,504 $ 384,380 Less current portion $ (231,504 ) $ (384,380 ) Total long-term $ - $ - ** Currently in default
notes payable, related parties	The following table summarizes notes payable, related parties Type Original Amount Origination Date Maturity Date Annual Interest Rate Balance at September 30, 2021 Balance at December 31, 2020 Note Payable, RP (k) $ 30,000 04/10/2018 01/15/2019 3 % $ - $ 30,000 Note Payable, RP (l) $ 380,000 06/20/2018 01/02/2020 8 % $ - $ 380,000 Note Payable, RP (m) $ 350,000 06/20/2018 01/02/2020 5 % $ - $ 285,214 Note Payable, RP (n)** $ 17,000 06/20/2018 01/02/2020 5 % $ 15,000 $ 17,000 Note Payable, RP ** $ 50,000 07/27/2018 11/30/2018 8 % $ 50,000 $ 50,000 Note Payable, RP (o) $ 5,000 10/09/2018 Demand 0 % $ - $ 5,000 Note Payable, RP (p) $ 5,000 10/19/2018 Demand 0 % $ 4,237 $ 5,000 Note Payable, RP ** $ 15,000 08/16/2019 02/16/2020 8 % $ 15,000 $ 15,000 Note Payable, RP (q) $ 2,000 02/11/2020 Demand 0 % $ - $ 2,000 Note Payable, RP (m) $ 84,034 02/16/2021 Demand 5 % $ 70,034 $ - Subtotal $ 154,271 $ 789,214 Debt discount $ - $ - Balance, net $ 154,271 $ 789,214 Less current portion $ (154,271 ) $ (789,214 ) Total long-term $ - $ - ** Currently in default
convertible notes payable	The following table summarizes convertible notes payable Type Original Amount Origination Date Maturity Date Annual Interest Rate Balance at September 30, 2021 Balance at December 31, 2020 Convertible Note Payable* ** $ 65,000 12/06/2018 12/06/2019 12 % $ 46 $ 46 Convertible Note Payable (r) $ 75,000 03/18/2019 12/13/2019 24 % $ - $ 177,795 Convertible Note Payable (s) $ 30,000 03/06/2020 03/05/2021 12 % $ - $ 21,662 Convertible Note Payable (t)* ** $ 150,000 04/10/2020 04/09/2021 12 % $ 65,000 $ 165,000 Convertible Note Payable (u) ** $ 300,000 08/27/2020 07/31/2021 12 % $ 270,000 $ 300,000 Convertible Note Payable (v) $ 53,500 09/22/2020 03/21/2022 12 % $ - $ 53,500 Convertible Note Payable (w) $ 87,500 09/24/2020 Demand 8 % $ 15,000 $ 40,000 Convertible Note Payable (x) $ 200,000 10/07/2020 10/06/2021 5 % $ 200,000 $ 200,000 Convertible Note Payable (y) $ 200,000 10/16/2020 10/15/2021 5 % $ 200,000 $ 200,000 Convertible Note Payable (z) $ 300,000 11/11/2020 11/10/2021 5 % $ 300,000 $ 300,000 Convertible Note Payable (aa) $ 150,000 12/29/2020 12/28/2021 5 % $ 150,000 $ 150,000 Convertible Note Payable (bb) $ 150,000 01/27/2021 01/27/2022 5 % $ 150,000 $ - Convertible Note Payable (cc) $ 128,000 02/22/2021 02/22/2022 12 % $ - $ - Convertible Note Payable (dd) $ 200,000 03/18/2021 03/18/2022 5 % $ 200,000 $ - Convertible Note Payable (ee) $ 83,000 03/26/2021 03/26/2022 12 % $ - $ - Convertible Note Payable (ff) $ 43,000 04/05/2021 04/05/2022 12 % $ - $ - Convertible Note Payable (gg) $ 200,000 04/14/2021 04/14/2022 5 % $ 200,000 $ - Convertible Note Payable (hh) $ 128,000 05/03/2021 05/03/2022 12 % $ 128,000 $ - Subtotal $ 1,876,046 $ 1,608,003 Debt discount $ (1,708 ) $ - Balance, net $ 1,876,338 $ 1,608,003 Less current portion $ (1,876,338 ) $ (1,554,503 ) Total long-term - 53,500 * Embedded conversion feature accounted for as a derivative liability at period end

NOTE 7. DERIVATIVE LIABILITIES

NOTE 7. DERIVATIVE LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2021
Note 7. Derivative Liabilities
summary of changes in the fair value of the Company's Level 3 financial liabilities	The table below sets forth a summary of changes in the fair value of the Company's Level 3 financial liabilities September 30, December 31, Balance at the beginning of period $ 7,102,801 $ 10,517,873 Original discount limited to proceeds of notes - 166,000 Settlement of derivative instruments (3,792,104 ) (16,824,669 ) Change in fair value of embedded conversion option (1,749,277 ) 13,243,597 Balance at the end of the period $ 1,561,420 $ 7,102,801
assumptions used in the calculations	Significant changes in any of these inputs in isolation would result in a significant change in the fair value measurement. As required, these are classified based on the lowest level of input that is significant to the fair value measurement. The following table shows the assumptions used in the calculations Expected Volatility Risk-free Interest Rate Expected Dividend Yield Expected Life (in years) At September 30, 2021 113 249 % 0.09 0.76 % 0 % 1.00 3.91

NOTE 9. STOCK OPTIONS (Tables)

NOTE 9. STOCK OPTIONS (Tables)	9 Months Ended
	Sep. 30, 2021
Note 9. Stock Options
options issued and outstanding	Below is a table summarizing the options issued and outstanding Number of Weighted average exercise price Balance, December 31, 2020 200,000 2.00 Granted - - Expired - - Settled - - Balance, September 30, 2021 200,000 2.00
As at September 30, 2021, the following share stock options were outstanding	As at September 30, 2021, the following share stock options were outstanding Date Number Number Exercise Weighted Average Remaining Contractual Expiration Proceeds to Company if Issued Outstanding Exercisable Price $ Life (Years) Date Exercised 01/26/2017 200,000 200,000 2.00 0.32 01/26/2022 400,000 200,000 200,000 $ 400,000

NOTE 10. WARRANTS (Tables)

NOTE 10. WARRANTS (Tables)	9 Months Ended
	Sep. 30, 2021
Note 10. Warrants
continuity of share purchase warrants	The following table summarizes the continuity of share purchase warrants Number of Weighted average exercise price Balance, December 31, 2020 260,500,000 0.00283 Settled - - Granted - - Exercised (142,857,143 ) 0.00035 Balance, September 30, 2021 117,642,857 0.00584
As at September 30, 2021, the following share purchase warrants were outstanding	As at September 30, 2021, the following share purchase warrants were outstanding Date Number Number Exercise Weighted Average Remaining Contractual Expiration Proceeds to Company if Issued Outstanding Exercisable Price $ Life (Years) Date Exercised 12/3/2018 500,000 500,000 0.10 2.18 12/3/2023 50,000 3/31/2019 107,142,857 107,142,857 * 0.00035 * 2.45 03/13/2024 37,500 8/26/2020 10,000,000 * 10,000,000 * 0.06 * 3.91 8/26/2025 600,000 117,642,857 117,642,857 $ 687,500

financial assets and liabilitie

financial assets and liabilities carried at fair value measured on a recurring basis (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]
Derivative liability (1)	$ 1,561,420	$ 7,102,801	$ 10,517,873
Total	1,561,420	7,102,801
Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability (1)
Total
Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability (1)
Total
Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability (1)	1,561,420	7,102,801
Total	$ 1,561,420	$ 7,102,801

Basic income (loss) per share (

Basic income (loss) per share (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Numerator:
Net income (loss)	$ (146,187)	$ (3,805,958)	$ 3,207,572	$ (7,338,523)
(Gain) loss on change in fair value of derivative liability			(1,641,616)
Gain on settlement of debt			(3,792,104)
Interest expense			30,617
Adjusted net income (loss)	$ (146,187)	$ (3,805,958)	$ (2,195,531)	$ (7,338,523)
Denominator: Weighted average shares outstanding used in computing net income (loss) per share
Basic	773,082,751	608,601,357	760,229,694	575,094,639
Effect of dilutive warrants			203,745,854
Effect of convertible note weighted shares			60,456,989
Diluted	773,082,751	608,601,357	1,024,432,537	575,094,639
Net income (loss) per share applicable to common shareholders:
Basic	$ 0	$ (0.01)	$ 0	$ (0.01)
Diluted	$ 0	$ (0.01)	$ 0	$ (0.01)

NOTE 2. GOING CONCERN (Details

NOTE 2. GOING CONCERN (Details Narrative) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Retained Earnings (Accumulated Deficit)	$ (27,380,040)	$ (30,587,612)
Banking Regulation, Total Capital, Actual	$ (5,563,299)

Property and equipment (Details

Property and equipment (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Leasehold improvements	$ 33,770	$ 18,840
Machinery and leased equipment	365,483	365,483
Machinery and equipment not yet in service	32,580	32,580
Office equipment and furniture	52,566	39,357
Website	2,760	2,760
Total property and equipment	487,159	459,020
Less: Accumulated Depreciation	(167,028)	(100,301)
Property and equipment, net	$ 320,131	$ 358,719

NOTE 3. PROPERTY AND EQUIPMEN_2

NOTE 3. PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Property, Plant and Equipment [Abstract]
Equipment Expense	$ 66,726	$ 27,085

Intangible assets (Details)

Intangible assets (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Patents	$ 4,505,489	$ 4,505,489
Technology rights	200,000	200,000
Intangibles, at cost	4,705,489	4,705,489
Less: Accumulated amortization	(1,533,831)	(1,305,465)
Net Carrying Amount	$ 3,171,658	$ 3,400,024

Estimated Future Amortization E

Estimated Future Amortization Expense (Details)	Sep. 30, 2021USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
For year ending December 31, 2021 - remaining	$ 76,122
For year ending December 31, 2022	304,488
For year ending December 31, 2023	304,488
For year ending December 31, 2024	304,488
For year ending December 31, 2025	304,488
Thereafter	1,877,584
Total	$ 3,171,658

NOTE 4. INTANGIBLE ASSETS (Deta

NOTE 4. INTANGIBLE ASSETS (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of Intangible Assets	$ 228,366	$ 228,283

components of lease expenses (D

components of lease expenses (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Leases [Abstract]
Total operating lease cost	$ 59,750
Lease payments	127,700	40,440
Cost	176,213
Accumulated amortization	(44,411)
Impairment	(39,030)
Net carrying value	$ 92,772

Future minimum lease payments r

Future minimum lease payments related to lease obligations (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Leases [Abstract]
2021	$ 13,500
2022	54,000
2023	45,000
Total minimum lease payments	112,500
Less: amount of lease payments representing effects of discounting	(19,728)
Present value of future minimum lease payments	92,772
Less: current obligations under leases	(40,127)
Lease liabilities, net of current portion	$ 52,645	$ 83,420

NOTE 5. LEASES (Details Narrati

NOTE 5. LEASES (Details Narrative) - USD ($)	3 Months Ended	6 Months Ended	9 Months Ended	11 Months Ended	12 Months Ended
	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2021	Jun. 30, 2021
Leases [Abstract]
Operating Leases, Rent Expense, Net	$ 7,650				$ 7,500
[custom:OperatingLeasesRentExpenseNet1]				$ 4,500
Operating Lease, Expense			$ 40,500
[custom:OperatingLeasesRentExpenseNet2]		$ 2,750
[custom:OperatingLeaseExpense1]			19,250
Operating Lease, Impairment Loss			$ 39,030

notes payable (Details)

notes payable (Details) - USD ($)	1 Months Ended	9 Months Ended
	Dec. 31, 2020	Sep. 30, 2021
Short-term Debt [Line Items]
Notes and Loans Payable, Current	$ (384,380)	$ (231,504)
Notes Payable 1 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 25,000
Debt Instrument, Issuance Date		May 8, 2017
Debt Instrument, Interest Rate During Period		0.00%
Long-term Debt, Gross	27,500	$ 22,500
Long-term Debt, Gross		$ 27,500
Debt Instrument, Maturity Date		Jun. 30, 2018
Long-term Debt, Gross	27,500	$ 22,500
Notes Payable 2 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 8,700
Debt Instrument, Issuance Date		Nov. 15, 2018
Debt Instrument, Interest Rate During Period		10.00%
Long-term Debt, Gross	8,700
Long-term Debt, Gross		$ 8,700
Debt Instrument, Maturity Date		Jun. 30, 2019
Long-term Debt, Gross	8,700
Notes Payable 3 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 118,644
Debt Instrument, Issuance Date		May 5, 2020
Debt Instrument, Interest Rate During Period		8.00%
Long-term Debt, Gross	110,644	$ 110,644
Long-term Debt, Gross		$ 110,644
Debt Instrument, Maturity Date		May 5, 2021
Long-term Debt, Gross	110,644	$ 110,644
Notes Payable 4 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 199,500
Debt Instrument, Issuance Date		Oct. 1, 2020
Debt Instrument, Interest Rate During Period		66.00%
Long-term Debt, Gross	149,573
Long-term Debt, Gross		$ 149,573
Debt Instrument, Maturity Date		Sep. 28, 2021
Long-term Debt, Gross	149,573
Notes Payable 5 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 126,000
Debt Instrument, Issuance Date		Nov. 3, 2020
Debt Instrument, Interest Rate During Period		166.00%
Long-term Debt, Gross	85,050
Long-term Debt, Gross		$ 85,050
Debt Instrument, Maturity Date		Apr. 23, 2021
Long-term Debt, Gross	85,050
Notes Payable 6 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 113,980
Debt Instrument, Issuance Date		Nov. 4, 2020
Debt Instrument, Interest Rate During Period		210.00%
Long-term Debt, Gross	65,988
Long-term Debt, Gross		$ 65,988
Debt Instrument, Maturity Date		Mar. 15, 2021
Long-term Debt, Gross	65,988
Notes Payable 7 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 177,800
Debt Instrument, Issuance Date		Jan. 2, 2021
Debt Instrument, Interest Rate During Period		116.00%
Long-term Debt, Gross
Long-term Debt, Gross
Debt Instrument, Maturity Date		Jul. 12, 2021
Long-term Debt, Gross
Notes Payable 8 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 111,920
Debt Instrument, Issuance Date		Mar. 9, 2021
Debt Instrument, Interest Rate During Period		220.00%
Long-term Debt, Gross
Long-term Debt, Gross
Debt Instrument, Maturity Date		May 21, 2021
Long-term Debt, Gross
Notes Payable 9 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 29,686
Debt Instrument, Issuance Date		Mar. 9, 2021
Debt Instrument, Interest Rate During Period		34.00%
Long-term Debt, Gross
Long-term Debt, Gross
Long-term Debt, Gross
Notes Payable 10 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 222,400
Debt Instrument, Issuance Date		Jun. 1, 2021
Debt Instrument, Interest Rate During Period		181.00%
Long-term Debt, Gross		$ 76,985
Long-term Debt, Gross
Long-term Debt, Gross		76,985
Notes Payable 11 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 87,000
Debt Instrument, Issuance Date		Jun. 29, 2021
Debt Instrument, Interest Rate During Period		211.00%
Long-term Debt, Gross		$ 31,320
Long-term Debt, Gross
Long-term Debt, Gross		31,320
Notes Payable Total [Member]
Short-term Debt [Line Items]
Long-term Debt, Gross	384,380	231,504
Long-term Debt, Gross		384,380
[custom:NotesPayableSubtotal-0]	447,455	241,449
Debt Instrument, Unamortized Discount (Premium), Net	(63,075)	(9,945)
Long-term Debt, Gross	384,380	231,504
Notes and Loans Payable, Current	(384,380)	(231,504)
Long-term Debt, Excluding Current Maturities

notes payable, related parties

notes payable, related parties (Details) - USD ($)	1 Months Ended	9 Months Ended
	Dec. 31, 2020	Sep. 30, 2021
Short-term Debt [Line Items]
Notes Payable, Related Parties, Current	$ 789,214	$ 154,271
Notes Payable, Related Parties, Current	(789,214)	(154,271)
Notes Payable Related Party 1 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 30,000
Debt Instrument, Issuance Date		Apr. 10, 2018
Debt Instrument, Interest Rate During Period		3.00%
Long-term Debt, Gross	30,000
Long-term Debt, Gross		$ 30,000
Debt Instrument, Maturity Date		Jan. 15, 2019
Notes Payable Related Party 2 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 380,000
Debt Instrument, Issuance Date		Jun. 20, 2018
Debt Instrument, Interest Rate During Period		8.00%
Long-term Debt, Gross	380,000
Long-term Debt, Gross		$ 380,000
Debt Instrument, Maturity Date		Jan. 2, 2020
Notes Payable Related Party 3 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 350,000
Debt Instrument, Issuance Date		Jun. 20, 2018
Debt Instrument, Interest Rate During Period		5.00%
Long-term Debt, Gross	285,214
Long-term Debt, Gross		$ 285,214
Debt Instrument, Maturity Date		Jan. 2, 2020
Notes Payable Related Party 4 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 17,000
Debt Instrument, Issuance Date		Jun. 20, 2018
Debt Instrument, Interest Rate During Period		5.00%
Long-term Debt, Gross	17,000	$ 15,000
Long-term Debt, Gross		$ 17,000
Debt Instrument, Maturity Date		Jan. 2, 2020
Notes Payable Related Party 5 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 50,000
Debt Instrument, Issuance Date		Jul. 27, 2018
Debt Instrument, Interest Rate During Period		8.00%
Long-term Debt, Gross	50,000	$ 50,000
Long-term Debt, Gross		$ 50,000
Debt Instrument, Maturity Date		Nov. 30, 2018
Notes Payable Related Party 6 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 5,000
Debt Instrument, Issuance Date		Oct. 9, 2018
Debt Instrument, Interest Rate During Period		0.00%
Long-term Debt, Gross	5,000
Long-term Debt, Gross		5,000
Notes Payable Related Party 7 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 5,000
Debt Instrument, Issuance Date		Oct. 19, 2018
Debt Instrument, Interest Rate During Period		0.00%
Long-term Debt, Gross	5,000	$ 4,237
Long-term Debt, Gross		5,000
Notes Payable Related Party 8 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 15,000
Debt Instrument, Issuance Date		Aug. 16, 2019
Debt Instrument, Interest Rate During Period		8.00%
Long-term Debt, Gross	15,000	$ 15,000
Long-term Debt, Gross		$ 15,000
Debt Instrument, Maturity Date		Feb. 16, 2020
Notes Payable Related Party 9 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 2,000
Debt Instrument, Issuance Date		Feb. 11, 2020
Debt Instrument, Interest Rate During Period		0.00%
Long-term Debt, Gross	2,000
Long-term Debt, Gross		2,000
Notes Payable Related Party 10 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 84,034
Debt Instrument, Issuance Date		Feb. 16, 2021
Debt Instrument, Interest Rate During Period		5.00%
Long-term Debt, Gross		$ 70,034
Long-term Debt, Gross
Notes Payable Related Party Total [Member]
Short-term Debt [Line Items]
Notes Payable, Related Parties, Current	789,214	154,271
Debt Instrument, Unamortized Discount (Premium), Net
Notes Payable, Related Parties	789,214	154,271
Notes Payable, Related Parties, Current	(789,214)	(154,271)
Notes Payable, Related Parties, Noncurrent

convertible notes payable (Deta

convertible notes payable (Details) - USD ($)	1 Months Ended	2 Months Ended		3 Months Ended		4 Months Ended		5 Months Ended	9 Months Ended
	Dec. 31, 2020	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2021	Sep. 30, 2021	Dec. 31, 2020
Short-term Debt [Line Items]
Convertible Notes Payable, Current	$ (1,554,503)	$ (1,876,338)	$ (1,554,503)	$ (1,876,338)	$ (1,554,503)	$ (1,876,338)	$ (1,554,503)	$ (1,876,338)	$ (1,876,338)	$ (1,554,503)
Convertible Notes Payable, Noncurrent	53,500		53,500		53,500		53,500			53,500
Convertible Note Payable 1 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		65,000		65,000		65,000		65,000	$ 65,000
Debt Instrument, Issuance Date									Dec. 6, 2018
Debt Instrument, Interest Rate During Period									12.00%
Long-term Debt, Gross	46	46	46	46	46	46	46	46	$ 46	46
Long-term Debt, Gross									$ 46
Debt Instrument, Maturity Date									Dec. 6, 2019
Convertible Note Payable 2 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		75,000		75,000		75,000		75,000	$ 75,000
Debt Instrument, Issuance Date									Mar. 18, 2019
Debt Instrument, Interest Rate During Period									24.00%
Long-term Debt, Gross	177,795		177,795		177,795		177,795			177,795
Long-term Debt, Gross									$ 177,795
Debt Instrument, Maturity Date									Dec. 13, 2019
Convertible Note Payable 3 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		30,000		30,000		30,000		30,000	$ 30,000
Debt Instrument, Issuance Date									Mar. 6, 2020
Debt Instrument, Interest Rate During Period									12.00%
Long-term Debt, Gross	21,662		21,662		21,662		21,662			$ 21,662
Long-term Debt, Gross									$ 21,662
Debt Instrument, Maturity Date									Mar. 5, 2021
Convertible Note Payable 4 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		150,000		150,000		150,000		150,000	$ 150,000
Debt Instrument, Issuance Date									Apr. 10, 2020
Debt Instrument, Interest Rate During Period									12.00%	12.00%
Long-term Debt, Gross	165,000	65,000	165,000	65,000	165,000	65,000	165,000	65,000	$ 65,000	$ 165,000
Long-term Debt, Gross									$ 165,000
Debt Instrument, Maturity Date									Apr. 9, 2021
Convertible Note Payable 5 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		300,000		300,000		300,000		300,000	$ 300,000
Debt Instrument, Issuance Date									Aug. 27, 2020
Debt Instrument, Interest Rate During Period									12.00%
Long-term Debt, Gross	300,000	270,000	300,000	270,000	300,000	270,000	$ 300,000	270,000	$ 270,000	300,000
Long-term Debt, Gross									$ 300,000
Debt Instrument, Maturity Date									Jul. 31, 2021
Convertible Note Payable 6 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		53,500		53,500		53,500		53,500	$ 53,500
Debt Instrument, Issuance Date									Sep. 22, 2020
Debt Instrument, Interest Rate During Period							12.00%		12.00%
Long-term Debt, Gross	53,500		53,500		53,500		$ 53,500			53,500
Long-term Debt, Gross									$ 53,500
Debt Instrument, Maturity Date									Mar. 21, 2022
Convertible Note Payable 7 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		87,500		87,500		87,500		87,500	$ 87,500
Debt Instrument, Issuance Date									Sep. 24, 2020
Debt Instrument, Interest Rate During Period									8.00%
Long-term Debt, Gross	40,000	15,000	40,000	15,000	$ 40,000	15,000	40,000	15,000	$ 15,000	40,000
Long-term Debt, Gross									40,000
Convertible Note Payable 8 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		200,000		200,000		200,000		200,000	$ 200,000
Debt Instrument, Issuance Date									Oct. 7, 2020
Debt Instrument, Interest Rate During Period					5.00%				5.00%
Long-term Debt, Gross	200,000	200,000	200,000	200,000	$ 200,000	200,000	200,000	200,000	$ 200,000	200,000
Long-term Debt, Gross									$ 200,000
Debt Instrument, Maturity Date									Oct. 6, 2021
Convertible Note Payable 9 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		200,000		200,000		200,000		200,000	$ 200,000
Debt Instrument, Issuance Date									Oct. 16, 2020
Debt Instrument, Interest Rate During Period					5.00%				5.00%
Long-term Debt, Gross	200,000	200,000	$ 200,000	200,000	$ 200,000	200,000	200,000	200,000	$ 200,000	200,000
Long-term Debt, Gross									$ 200,000
Debt Instrument, Maturity Date									Oct. 15, 2021
Convertible Note Payable 10 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		300,000		300,000		300,000		300,000	$ 300,000
Debt Instrument, Issuance Date									Nov. 11, 2020
Debt Instrument, Interest Rate During Period			5.00%						5.00%
Long-term Debt, Gross	$ 300,000	300,000	$ 300,000	300,000	300,000	300,000	300,000	300,000	$ 300,000	300,000
Long-term Debt, Gross									$ 300,000
Debt Instrument, Maturity Date									Nov. 10, 2021
Convertible Note Payable 11 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		150,000		150,000		150,000		150,000	$ 150,000
Debt Instrument, Issuance Date									Dec. 29, 2020
Debt Instrument, Interest Rate During Period	5.00%								5.00%
Long-term Debt, Gross	$ 150,000	150,000	150,000	150,000	150,000	150,000	150,000	150,000	$ 150,000	150,000
Long-term Debt, Gross									$ 150,000
Debt Instrument, Maturity Date									Dec. 28, 2021
Convertible Note Payable 12 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		150,000		150,000		150,000		150,000	$ 150,000
Debt Instrument, Issuance Date									Jan. 27, 2021
Debt Instrument, Interest Rate During Period									5.00%
Long-term Debt, Gross		150,000		150,000		150,000		150,000	$ 150,000
Long-term Debt, Gross
Debt Instrument, Maturity Date									Jan. 27, 2022
Convertible Note Payable 13 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		128,000		128,000		128,000		$ 128,000	$ 128,000
Debt Instrument, Issuance Date									Feb. 22, 2021
Debt Instrument, Interest Rate During Period								12.00%	12.00%
Long-term Debt, Gross
Long-term Debt, Gross
Debt Instrument, Maturity Date									Feb. 22, 2022
Convertible Note Payable 14 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		200,000		200,000		$ 200,000		200,000	$ 200,000
Debt Instrument, Issuance Date									Mar. 18, 2021
Debt Instrument, Interest Rate During Period						5.00%			5.00%
Long-term Debt, Gross		200,000		200,000		$ 200,000		200,000	$ 200,000
Long-term Debt, Gross
Debt Instrument, Maturity Date									Mar. 18, 2022
Convertible Note Payable 15 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		83,000		83,000		$ 83,000		83,000	$ 83,000
Debt Instrument, Issuance Date									Mar. 26, 2021
Debt Instrument, Interest Rate During Period						12.00%			12.00%
Long-term Debt, Gross
Long-term Debt, Gross
Debt Instrument, Maturity Date									Mar. 26, 2022
Convertible Note Payable 16 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		43,000		$ 43,000		43,000		43,000	$ 43,000
Debt Instrument, Issuance Date									Apr. 5, 2021
Debt Instrument, Interest Rate During Period				12.00%					12.00%
Long-term Debt, Gross
Long-term Debt, Gross
Debt Instrument, Maturity Date									Apr. 5, 2022
Convertible Note Payable 17 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		200,000		$ 200,000		200,000		200,000	$ 200,000
Debt Instrument, Issuance Date									Apr. 14, 2021
Debt Instrument, Interest Rate During Period				5.00%					5.00%
Long-term Debt, Gross		200,000		$ 200,000		200,000		200,000	$ 200,000
Long-term Debt, Gross
Debt Instrument, Maturity Date									Apr. 14, 2022
Convertible Note Payable 18 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount		$ 128,000		128,000		128,000		128,000	$ 128,000
Debt Instrument, Issuance Date									May 3, 2021
Debt Instrument, Interest Rate During Period		12.00%							12.00%
Long-term Debt, Gross		$ 128,000		128,000		128,000		128,000	$ 128,000
Long-term Debt, Gross
Debt Instrument, Maturity Date									May 3, 2022
Convertible Note Payable Total [Member]
Short-term Debt [Line Items]
Convertible Debt	1,608,003	1,876,046	1,608,003	1,876,046	1,608,003	1,876,046	1,608,003	1,876,046	$ 1,876,046	1,608,003
Debt Instrument, Unamortized Discount (Premium), Net		(1,708)		(1,708)		(1,708)		(1,708)	(1,708)
Convertible Debt, Current	1,608,003	1,876,338	1,608,003	1,876,338	1,608,003	1,876,338	1,608,003	1,876,338	1,876,338	1,608,003
Convertible Notes Payable, Current	(1,554,503)	(1,876,338)	(1,554,503)	(1,876,338)	(1,554,503)	(1,876,338)	(1,554,503)	(1,876,338)	(1,876,338)	(1,554,503)
Convertible Notes Payable, Noncurrent	$ 53,500		$ 53,500		$ 53,500		$ 53,500			$ 53,500

NOTE 6. NOTES PAYABLE (Details

NOTE 6. NOTES PAYABLE (Details Narrative) - USD ($)	1 Months Ended		2 Months Ended		3 Months Ended					4 Months Ended		5 Months Ended	9 Months Ended			12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2021	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2020	May 03, 2021	Apr. 14, 2021	Apr. 05, 2021	Mar. 26, 2021	Mar. 18, 2021	Feb. 22, 2021	Feb. 16, 2021	Jan. 27, 2021	Dec. 29, 2020	Nov. 11, 2020	Oct. 16, 2020	Oct. 07, 2020	Sep. 22, 2020	Apr. 10, 2020
Short-term Debt [Line Items]
[custom:FutureReceivablesSoldToNonrelatedPartyRepaymentOfAdvanceWeeklyAmount]							$ 3,841
Amortization of Debt Issuance Costs and Discounts													$ 12,000		$ 201,388
Gain (Loss) on Extinguishment of Debt					$ 361,357			$ (3,670,393)					3,689,055		9,993,528
Repayments of Convertible Debt													673,989		356,888
Proceeds from Convertible Debt													920,000		$ 613,000
Stock Issued During Period, Shares, Conversion of Convertible Securities						25,000,000
Stock Issued During Period, Value, Conversion of Convertible Securities					124,000	$ 25,000		$ 542,958	$ 396,710
Notes Payable 1 [Member]
Short-term Debt [Line Items]
Repayments of Other Debt													5,000
[custom:NoteBalance-0]	$ 22,500		$ 22,500		22,500					$ 22,500		$ 22,500	22,500
Debt Instrument, Face Amount	25,000		25,000		25,000					25,000		25,000	$ 25,000
Debt Instrument, Interest Rate During Period													0.00%
Notes Payable 2 [Member]
Short-term Debt [Line Items]
Repayments of Other Debt													$ 8,700
[custom:NoteBalance-0]	0		0		0					0		0	0
Debt Instrument, Face Amount	8,700		8,700		8,700					8,700		8,700	$ 8,700
Debt Instrument, Interest Rate During Period													10.00%
Notes Payable 4 [Member]
Short-term Debt [Line Items]
[custom:NoteBalance-0]	0		0		0					0		0	$ 0
[custom:FutureReceivablesSoldToNonrelatedParty]							199,500
[custom:FutureReceivablesSoldToNonrelatedPartyLoanFees]							53,250
Proceeds from Other Debt							146,250
Amortization of Debt Issuance Costs and Discounts													30,642
Debt Instrument, Face Amount	199,500		199,500		199,500					199,500		199,500	$ 199,500
Debt Instrument, Interest Rate During Period													66.00%
Notes Payable 5 [Member]
Short-term Debt [Line Items]
Repayments of Other Debt													$ 85,050
[custom:NoteBalance-0]	0		0		0					0		0	0
[custom:FutureReceivablesSoldToNonrelatedParty]				$ 126,000
[custom:FutureReceivablesSoldToNonrelatedPartyLoanFees]				39,650
Proceeds from Other Debt				86,350
Amortization of Debt Issuance Costs and Discounts													18,944
[custom:FutureReceivablesSoldToNonrelatedPartyRepaymentOfAdvanceDailyAmount]				1,050
Debt Instrument, Face Amount	126,000		126,000		126,000					126,000		126,000	$ 126,000
Debt Instrument, Interest Rate During Period													166.00%
Notes Payable 6 [Member]
Short-term Debt [Line Items]
Repayments of Other Debt													$ 65,988
[custom:NoteBalance-0]	0		0		0					0		0	0
[custom:FutureReceivablesSoldToNonrelatedParty]				113,980
[custom:FutureReceivablesSoldToNonrelatedPartyLoanFees]				34,440
Proceeds from Other Debt				79,540
[custom:FutureReceivablesSoldToNonrelatedPartyRepaymentOfAdvanceWeeklyAmount]				5,999
Amortization of Debt Issuance Costs and Discounts													13,489
Debt Instrument, Face Amount	113,980		113,980		113,980					113,980		113,980	$ 113,980
Debt Instrument, Interest Rate During Period													210.00%
Notes Payable 7 [Member]
Short-term Debt [Line Items]
Repayments of Other Debt													$ 43,600
[custom:NoteBalance-0]	0		0		0					0		0	0
[custom:FutureReceivablesSoldToNonrelatedParty]													177,800
[custom:FutureReceivablesSoldToNonrelatedPartyLoanFees]													39,795
Proceeds from Other Debt													102,011
[custom:FutureReceivablesSoldToNonrelatedPartyRepaymentOfAdvanceWeeklyAmount]													7,730
Amortization of Debt Issuance Costs and Discounts													39,795
[custom:FutureReceivablesSoldToNonrelatedPartyAmountsUsedToSettleLoan]													35,994
[custom:NoteRemainingAmount]													46,383
Gain (Loss) on Extinguishment of Debt													2,783
Debt Instrument, Face Amount	177,800		177,800		177,800					177,800		177,800	$ 177,800
Debt Instrument, Interest Rate During Period													116.00%
Notes Payable 8 [Member]
Short-term Debt [Line Items]
Repayments of Other Debt													$ 111,920
[custom:NoteBalance-0]	0		0		0					0		0	0
[custom:FutureReceivablesSoldToNonrelatedParty]										111,920
[custom:FutureReceivablesSoldToNonrelatedPartyLoanFees]										35,120
Proceeds from Other Debt										76,800
[custom:FutureReceivablesSoldToNonrelatedPartyRepaymentOfAdvanceWeeklyAmount]										1,399
Amortization of Debt Issuance Costs and Discounts													35,120
Debt Instrument, Face Amount	111,920		111,920		111,920					111,920		111,920	$ 111,920
Debt Instrument, Interest Rate During Period													220.00%
Notes Payable 9 [Member]
Short-term Debt [Line Items]
Repayments of Other Debt													$ 29,686
[custom:NoteBalance-0]	0		0		0					0		0	0
[custom:FutureReceivablesSoldToNonrelatedParty]										29,686
[custom:FutureReceivablesSoldToNonrelatedPartyLoanFees]										10,120
Proceeds from Other Debt										19,566
Amortization of Debt Issuance Costs and Discounts													10,120
Debt Instrument, Face Amount	29,686		29,686		29,686					29,686		29,686	$ 29,686
Debt Instrument, Interest Rate During Period													34.00%
Notes Payable 10 [Member]
Short-term Debt [Line Items]
Repayments of Other Debt													$ 145,415
[custom:NoteBalance-0]	70,999		70,999		70,999					70,999		70,999	70,999
[custom:FutureReceivablesSoldToNonrelatedParty]	222,400
[custom:FutureReceivablesSoldToNonrelatedPartyLoanFees]	8,000
Proceeds from Other Debt	152,000
[custom:FutureReceivablesSoldToNonrelatedPartyRepaymentOfAdvanceWeeklyAmount]	8,554
Amortization of Debt Issuance Costs and Discounts													64,414
[custom:FutureReceivablesSoldToNonrelatedPartyOriginalIssueDiscount]	62,400
[custom:DiscountBalanceOnNote-0]	5,986		5,986		5,986					5,986		5,986	5,986
Debt Instrument, Face Amount	222,400		222,400		222,400					222,400		222,400	$ 222,400
Debt Instrument, Interest Rate During Period													181.00%
Notes Payable 11 [Member]
Short-term Debt [Line Items]
Repayments of Other Debt													$ 55,680
[custom:NoteBalance-0]	27,361		27,361		27,361					27,361		27,361	27,361
[custom:FutureReceivablesSoldToNonrelatedParty]	87,000
[custom:FutureReceivablesSoldToNonrelatedPartyLoanFees]	27,000
Proceeds from Other Debt	60,000
Amortization of Debt Issuance Costs and Discounts													23,041
[custom:DiscountBalanceOnNote-0]	3,959		3,959		3,959					3,959		3,959	3,959
Debt Instrument, Face Amount	87,000		87,000		87,000					87,000		87,000	$ 87,000
Debt Instrument, Interest Rate During Period													211.00%
Notes Payable Related Party 1 [Member]
Short-term Debt [Line Items]
Repayments of Other Debt													$ 30,000
[custom:NoteBalance-0]	0		0		0					0		0	0
Debt Instrument, Face Amount	30,000		30,000		30,000					30,000		$ 30,000	$ 30,000
Debt Instrument, Interest Rate During Period													3.00%
Notes Payable Related Party 2 [Member]
Short-term Debt [Line Items]
[custom:StockIssuedDuringPeriodSharesSettlementOfNotePayable]												2,663,299
[custom:StockIssuedDuringPeriodValueSettlementOfNotePayablePrincipal]												$ 380,000
[custom:StockIssuedDuringPeriodValueSettlementOfNotePayableAccruedInterest]												26,153
[custom:NotePayableRelatedPartyFairValueOfSharesIssued]													$ 74,572
[custom:DifferenceBetweenFairValueOfSharesAndExtinguishmentOfDebtRecordedAsAdditionalPaidInCapital-0]	328,919		328,919		328,919					328,919		328,919	328,919
Debt Instrument, Face Amount	380,000		380,000		380,000					380,000		380,000	$ 380,000
Debt Instrument, Interest Rate During Period													8.00%
Notes Payable Related Party 3 [Member]
Short-term Debt [Line Items]
Repayments of Other Debt													$ 14,000
[custom:NoteBalance-0]	70,034		70,034		70,034					70,034		$ 70,034	70,034
[custom:StockIssuedDuringPeriodSharesSettlementOfNotePayable]												1,803,279
[custom:StockIssuedDuringPeriodValueSettlementOfNotePayablePrincipal]												$ 275,000
[custom:NotePayableRelatedPartyFairValueOfSharesIssued]													50,492
[custom:DifferenceBetweenFairValueOfSharesAndExtinguishmentOfDebtRecordedAsAdditionalPaidInCapital-0]	194,861		194,861		194,861					194,861		194,861	194,861
[custom:StockIssuedDuringPeriodValueSettlementOfNotePayable]												247,270
[custom:NotePayableRelatedPartyRemainingBalance-0]																							$ 331,304
[custom:NotePayableRelatedPartyNewNoteIssuedForRemainingBalanceOwed-0]																							$ 84,034
[custom:NotePayableRelatedPartyNewNoteIssuedInterestRatePerAnnum-0]																							5.00%
Debt Instrument, Face Amount	350,000		350,000		350,000					350,000		350,000	$ 350,000
Debt Instrument, Interest Rate During Period													5.00%
Notes Payable Related Party 4 [Member]
Short-term Debt [Line Items]
Repayments of Other Debt													$ 2,000
[custom:NoteBalance-0]	15,000		15,000		15,000					15,000		15,000	15,000
Debt Instrument, Face Amount	17,000		17,000		17,000					17,000		17,000	$ 17,000
Debt Instrument, Interest Rate During Period													5.00%
Notes Payable Related Party 6 [Member]
Short-term Debt [Line Items]
Repayments of Other Debt													$ 5,000
[custom:NoteBalance-0]	0		0		0					0		0	0
Debt Instrument, Face Amount	5,000		5,000		5,000					5,000		5,000	$ 5,000
Debt Instrument, Interest Rate During Period													0.00%
Notes Payable Related Party 7 [Member]
Short-term Debt [Line Items]
Repayments of Other Debt													$ 763
[custom:NoteBalance-0]	4,237		4,237		4,237					4,237		4,237	4,237
Debt Instrument, Face Amount	5,000		5,000		5,000					5,000		5,000	$ 5,000
Debt Instrument, Interest Rate During Period													0.00%
Notes Payable Related Party 9 [Member]
Short-term Debt [Line Items]
Repayments of Other Debt													$ 2,000
[custom:NoteBalance-0]	0		0		0					0		0	0
Debt Instrument, Face Amount	2,000		2,000		2,000					2,000		2,000	$ 2,000
Debt Instrument, Interest Rate During Period													0.00%
Convertible Note Payable 2 [Member]
Short-term Debt [Line Items]
Gain (Loss) on Extinguishment of Debt													$ 20,364
Repayments of Convertible Debt													70,000
[custom:CashPaymentForSettlementOfDebt]													$ 40,000
[custom:StockIssuedDuringPeriodSharesConvertibleDebtSettlement]													8,000,000
[custom:StockIssuedDuringPeriodValueConvertibleDebtSettlement]													$ 124,000
Debt Instrument, Face Amount	75,000		$ 75,000		75,000					75,000		75,000	$ 75,000
Debt Instrument, Interest Rate During Period													24.00%
Convertible Note Payable 3 [Member]
Short-term Debt [Line Items]
[custom:CashlessExerciseToPurchaseCommonStockGrantedToNonrelatedPartyToSettleConvertibleDebt]			1,921,875										1,921,875
[custom:CashlessExerciseToPurchaseCommonStockGrantedToNonrelatedPartyToSettleConvertibleDebtPricePerShare]			$ 0.032
[custom:ShareReleaseAgreementByNonrelatedPartyToSettleConvertibleDebt]			60,072,853
[custom:CashPaymentToNonrelatedPartyToSettleConvertibleDebt]			$ 36,994										$ 36,994
[custom:AdditionalDefaultPenaltiesIncurredOnConvertibleNote]													15,174
[custom:ConvertibleNotePayableOutstandingDebtBalance-0]	36,836		36,836		36,836					36,836		36,836	36,836
[custom:ConvertibleNotePayableOutstandingDebtAccruedInterest]													3,657
[custom:CashlessExerciseToPurchaseCommonStockGrantedToNonrelatedPartyToSettleConvertibleDebtFairValue]													34,594
[custom:LossOnSettlementDebtFromConvertibleDebtSettlement]													31,095
Debt Instrument, Face Amount	30,000		30,000		30,000					30,000		30,000	$ 30,000
Debt Instrument, Interest Rate During Period													12.00%
Convertible Note Payable 4 [Member]
Short-term Debt [Line Items]
Repayments of Convertible Debt													$ 100,000
[custom:AdditionalDefaultPenaltiesIncurredOnConvertibleNote]																$ 15,000
[custom:ConvertibleNotePayableOutstandingDebtBalance-0]	65,000		65,000		65,000					65,000		65,000	65,000
Debt Instrument, Face Amount	150,000		150,000		150,000					150,000		150,000	$ 150,000																	$ 150,000
[custom:ConvertibleDebtOriginalIssueDiscount]														$ 18,000
Proceeds from Convertible Debt														$ 132,000
Debt Instrument, Interest Rate During Period													12.00%	12.00%
[custom:ConvertibleDebtInitialFairValueOfConversionFeature]														$ 507,847
[custom:ConvertibleDebtDiscountToNotePayable]														132,000
[custom:ConvertibleDebtInitialDerivativeExpense]														375,847
[custom:ConvertibleNotePayableOutstandingDebtPrincipal-0]		$ 165,000		$ 165,000			$ 165,000				$ 165,000			$ 165,000		$ 165,000
Convertible Note Payable 5 [Member]
Short-term Debt [Line Items]
Repayments of Convertible Debt													$ 30,000
[custom:ConvertibleNotePayableOutstandingDebtBalance-0]	270,000		270,000		270,000					270,000		270,000	270,000
Debt Instrument, Face Amount	300,000		300,000		300,000					300,000		300,000	$ 300,000
Debt Instrument, Interest Rate During Period													12.00%
Convertible Note Payable 6 [Member]
Short-term Debt [Line Items]
Repayments of Convertible Debt													$ 53,500
Debt Instrument, Face Amount	53,500		53,500		53,500					53,500		53,500	$ 53,500																$ 53,500
[custom:ConvertibleDebtOriginalIssueDiscount]											3,500
Proceeds from Convertible Debt											$ 50,000
Debt Instrument, Interest Rate During Period											12.00%		12.00%
[custom:RepaymentsOfConvertibleDebtInterestAndPrepaymentPenalties]													$ 25,882
Convertible Note Payable 7 [Member]
Short-term Debt [Line Items]
[custom:ConvertibleNotePayableOutstandingDebtBalance-0]	15,000		15,000		15,000					15,000		15,000	15,000
Debt Instrument, Face Amount	87,500		87,500		87,500					87,500		87,500	$ 87,500
Debt Instrument, Interest Rate During Period													8.00%
Stock Issued During Period, Shares, Conversion of Convertible Securities													25,000,000
Stock Issued During Period, Value, Conversion of Convertible Securities													$ 25,000
[custom:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities1]													15,000,000
[custom:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities1]													$ 15,000
Convertible Note Payable 8 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount	200,000		200,000		200,000					200,000		200,000	$ 200,000															$ 200,000
Debt Instrument, Interest Rate During Period							5.00%						5.00%
Convertible Note Payable 9 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount	200,000		200,000		200,000					200,000		200,000	$ 200,000														$ 200,000
Debt Instrument, Interest Rate During Period							5.00%						5.00%
Convertible Note Payable 10 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount	300,000		300,000		300,000					300,000		300,000	$ 300,000													$ 300,000
Debt Instrument, Interest Rate During Period				5.00%									5.00%
Convertible Note Payable 11 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount	150,000		150,000		150,000					150,000		150,000	$ 150,000												$ 150,000
Debt Instrument, Interest Rate During Period		5.00%											5.00%
Convertible Note Payable 12 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount	150,000		150,000		150,000					150,000		150,000	$ 150,000											$ 150,000
Debt Instrument, Interest Rate During Period													5.00%
Convertible Note Payable 13 [Member]
Short-term Debt [Line Items]
Repayments of Convertible Debt													$ 128,000
Debt Instrument, Face Amount	128,000		128,000		128,000					128,000		128,000	$ 128,000									$ 128,000
[custom:ConvertibleDebtOriginalIssueDiscount]												3,000
Proceeds from Convertible Debt												$ 125,000
Debt Instrument, Interest Rate During Period												12.00%	12.00%
[custom:RepaymentsOfConvertibleDebtInterestAndOther]													$ 51,000
Convertible Note Payable 14 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount	200,000		200,000		200,000					$ 200,000		$ 200,000	$ 200,000								$ 200,000
Debt Instrument, Interest Rate During Period										5.00%			5.00%
Convertible Note Payable 15 [Member]
Short-term Debt [Line Items]
Repayments of Convertible Debt													$ 83,000
Debt Instrument, Face Amount	83,000		83,000		83,000					$ 83,000		83,000	$ 83,000							$ 83,000
[custom:ConvertibleDebtOriginalIssueDiscount]										3,000
Proceeds from Convertible Debt										$ 80,000
Debt Instrument, Interest Rate During Period										12.00%			12.00%
[custom:RepaymentsOfConvertibleDebtInterestAndOther]													$ 39,694
Convertible Note Payable 16 [Member]
Short-term Debt [Line Items]
Repayments of Convertible Debt													43,000
Debt Instrument, Face Amount	43,000		43,000		43,000					$ 43,000		43,000	$ 43,000						$ 43,000
[custom:ConvertibleDebtOriginalIssueDiscount]					3,000
Proceeds from Convertible Debt					$ 40,000
Debt Instrument, Interest Rate During Period					12.00%								12.00%
[custom:RepaymentsOfConvertibleDebtInterestAndOther]													$ 12,270
Convertible Note Payable 17 [Member]
Short-term Debt [Line Items]
Debt Instrument, Face Amount	200,000		200,000		$ 200,000					200,000		200,000	$ 200,000					$ 200,000
Debt Instrument, Interest Rate During Period					5.00%								5.00%
Convertible Note Payable 18 [Member]
Short-term Debt [Line Items]
Repayments of Convertible Debt													$ 128,000
Debt Instrument, Face Amount	$ 128,000		128,000		$ 128,000					$ 128,000		$ 128,000	$ 128,000				$ 128,000
[custom:ConvertibleDebtOriginalIssueDiscount]			3,000
Proceeds from Convertible Debt			$ 125,000
Debt Instrument, Interest Rate During Period			12.00%										12.00%
[custom:RepaymentsOfConvertibleDebtInterestAndOther]													$ 61,952

summary of changes in the fair

summary of changes in the fair value of the Company's Level 3 financial liabilities (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Note 7. Derivative Liabilities
Balance at the beginning of period	$ 7,102,801	$ 10,517,873
Original discount limited to proceeds of notes		166,000
Settlement of derivative instruments	(3,792,104)	(16,824,669)
Change in fair value of embedded conversion option	(1,749,277)	13,243,597
Balance at the end of the period	$ 1,561,420	$ 7,102,801

assumptions used in the calcula

assumptions used in the calculations (Details) - Trading Liabilities [Member]	9 Months Ended
	Sep. 30, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum	113.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum	249.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum	0.09%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum	0.76%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%
[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2]	1 year
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	3 years 10 months 28 days

NOTE 8. STOCKHOLDERS' DEFICIT (

NOTE 8. STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended					9 Months Ended	12 Months Ended
	Dec. 31, 2018	Sep. 30, 2021	Jun. 30, 2021	May 31, 2021	Mar. 31, 2021	Jun. 30, 2020	Sep. 30, 2021	Dec. 31, 2019	Feb. 16, 2021	Jan. 04, 2021	Dec. 31, 2020	Oct. 04, 2019	Sep. 18, 2019	Aug. 13, 2019	Apr. 12, 2019	Mar. 23, 2018
Class of Stock [Line Items]
Preferred Stock, Shares Authorized																10,000,000
Preferred Stock, Par or Stated Value Per Share																$ 0.001
[custom:PreferredSeriesAStockOfferingAuthorized]	1,000,000
[custom:PreferredSeriesAStockOfferingAuthorizedOfferingPrice]	$ 0.10
[custom:ProceedsFromPreferredSeriesAStockSubscriptions]	$ 60,000
[custom:StockIssuedDuringPeriodSharesPreferredSeriesAStockSubscriptions]	600,000
[custom:StockIssuedDuringPeriodToOfficersSeriesBPreferredStock]								1,000,000
[custom:InitialRedemptionAmountOfSeriesBPreferredStockClassifiedAsMezzanineEquityValue]								$ 158,247
Preferred Stock, Value, Issued		$ 218,645					$ 218,645				$ 258,645
[custom:ConversionOfPreferredSeriesCStockShares]					40,000
[custom:CommonStockIssuedInConversionOfPreferredSeriesCStockShares]					4,000,000
Common Stock, Par or Stated Value Per Share		$ 0.001					$ 0.001				$ 0.001	$ 0.001				$ 0.001
[custom:CommonStockSharesAuthorizedFormerNumber-0]												300,000,000				100,000,000
Common Stock, Shares Authorized		1,000,000,000					1,000,000,000				1,000,000,000	1,000,000,000				300,000,000
Common Stock, Shares, Outstanding		780,126,229					780,126,229				722,487,846
Stock Issued During Period, Shares, Conversion of Convertible Securities					25,000,000
[custom:ConvertibleNoteRemainingBalanceAfterIssuanceOfCommonSharesToSettleNote-0]										$ 40,000
[custom:StockIssuedDuringPeriodSharesSettlementOfNotesPayable1]					1,803,279
[custom:StockIssuedDuringPeriodValueSettlementOfNotesPayable1]					$ 247,270
[custom:ConvertibleNoteOriginalAmount1-0]									$ 275,000
[custom:ConvertibleNoteRemainingBalanceAfterIssuanceOfCommonSharesToSettleNote1-0]									$ 331,304
[custom:StockIssuedDuringPeriodSharesSettlementOfNotesPayable2]					2,663,299
[custom:StockIssuedDuringPeriodValueSettlementOfNotesPayable2]					$ 380,000
[custom:StockIssuedDuringPeriodValueSettlementOfNotesPayableAccruedInterest2]					$ 26,153
[custom:ConsultingAgreementCommonStockIssuedShares]				2,500,000
[custom:ConsultingAgreementCommonStockIssuedValue]				$ 62,750
[custom:StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants]		1,921,875
[custom:StockIssuedDuringPeriodSharesPursuantToEmploymentAgreementWithOfficer]		1,000,000
[custom:StockIssuedDuringPeriodValuePursuantToEmploymentAgreementWithOfficer]		$ 18,990
Sale of Stock, Consideration Received on Transaction			$ 175,000			$ 140,000
[custom:StockIssuedDuringPeriodSharesSettlementOfConvertibleNotePayable]							8,000,000
[custom:StockIssuedDuringPeriodValueSettlementOfConvertibleNotePayableCashAmountPaid]							$ 21,000
[custom:StockIssuedDuringPeriodValueSettlementOfConvertibleNotePayable]							88,795
[custom:StockIssuedDuringPeriodValueSettlementOfConvertibleNotePayableAccruedInterest]							26,153
[custom:GainLossOnExtinguishmentOfDebtConvertibleNotePayable]							$ 20,364
[custom:StockIssuedDuringPeriodSharesGeneralReleaseAgreement]							2,000,000
[custom:StockIssuedDuringPeriodValueGeneralReleaseAgreement]							$ 28,400
Stock Issued For Cash 1 [Member]
Class of Stock [Line Items]
Sale of Stock, Number of Shares Issued in Transaction		3,750,000
Sale of Stock, Consideration Received on Transaction		$ 75,000
Stock Issued For Cash 2 [Member]
Class of Stock [Line Items]
Sale of Stock, Number of Shares Issued in Transaction		5,000,000
Sale of Stock, Consideration Received on Transaction		$ 100,000
Chief Executive Officer [Member]
Class of Stock [Line Items]
[custom:StockIssuedDuringPeriodToOfficersSeriesBPreferredStock]								500,000
Chief Financial Officer [Member]
Class of Stock [Line Items]
[custom:StockIssuedDuringPeriodToOfficersSeriesBPreferredStock]								500,000
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized		1,000,000					1,000,000				1,000,000
Preferred Stock, Par or Stated Value Per Share		$ 0.001					$ 0.001				$ 0.001
[custom:PreferredStockSharesDesignated-0]								1,000,000							1,000,000
Preferred Stock, Shares Issued		500,000					500,000				500,000
Preferred Stock, Shares Outstanding		500,000					500,000				500,000
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized		1,000,000					1,000,000				1,000,000
Preferred Stock, Par or Stated Value Per Share		$ 0.001					$ 0.001				$ 0.001
[custom:PreferredStockSharesDesignated-0]														1,000,000
Preferred Stock, Shares Issued		1,000,000					1,000,000				1,000,000
Preferred Stock, Shares Outstanding		1,000,000					1,000,000				1,000,000
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized		5,500,000					5,500,000				5,500,000
Preferred Stock, Par or Stated Value Per Share		$ 0.001					$ 0.001				$ 0.001
[custom:PreferredStockSharesDesignated-0]													5,500,000
Preferred Stock, Shares Issued											40,000
Preferred Stock, Shares Outstanding											40,000
[custom:PreferredStockSharesValuePerShare-0]											$ 1
Preferred Stock, Value, Issued											$ 40,000

options issued and outstanding

options issued and outstanding (Details) - $ / shares	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Note 9. Stock Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	200,000	200,000
Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price	$ 2	$ 2
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price

As at September 30, 2021, the f

As at September 30, 2021, the following share stock options were outstanding (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Offsetting Assets [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	200,000	200,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	200,000
Proceeds from Stock Options Exercised	$ 400,000
Equity Option [Member]
Offsetting Assets [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	200,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	200,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 2
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	3 months 26 days
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Jan. 26, 2022
Proceeds from Stock Options Exercised	$ 400,000

continuity of share purchase wa

continuity of share purchase warrants (Details) - $ / shares	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Note 10. Warrants
Class of Warrant or Right, Outstanding	117,642,857	260,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.00584	$ 0.00283
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised	(142,857,143)
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice]	$ 0.00035

As at September 30, 2021, the_2

As at September 30, 2021, the following share purchase warrants were outstanding (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Class of Warrant or Right, Outstanding	117,642,857	260,500,000
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable-0]	117,642,857
Proceeds from Warrant Exercises	$ 687,500
Warrant [Member]
Class of Warrant or Right, Outstanding	500,000
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable-0]	500,000
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePrice-0]	$ 0.10
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	2 years 2 months 5 days
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Dec. 3, 2023
Proceeds from Warrant Exercises	$ 50,000
Warrant 1 [Member]
Class of Warrant or Right, Outstanding	107,142,857
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable-0]	107,142,857
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePrice-0]	$ 0.00035
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	2 years 5 months 12 days
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Mar. 13, 2024
Proceeds from Warrant Exercises	$ 37,500
Warrant 2 [Member]
Class of Warrant or Right, Outstanding	10,000,000
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable-0]	10,000,000
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePrice-0]	$ 0.06
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	3 years 10 months 28 days
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Aug. 26, 2025
Proceeds from Warrant Exercises	$ 600,000

NOTE 10. WARRANTS (Details Narr

NOTE 10. WARRANTS (Details Narrative)	Sep. 30, 2021USD ($)
Note 10. Warrants
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding	$ 1,237,500

NOTE 12. COMMITMENTS AND CONT_2

NOTE 12. COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	2 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
[custom:OfficerContractAnnualSalaryAmount]	$ 70,000
[custom:OfficerContractIssuanceOfShares]	1,000,000
[custom:OfficerContractIssuanceOfSharesFairValueOfStock]	$ 18,990
[custom:CommitmentToAcquireInventoryTotalCost]		$ 61,150
[custom:CommitmentToAcquireInventoryAmountsPaid]		$ 30,575